6,140 results on '"Community-Acquired Infections microbiology"'
Search Results
2. Current Mycoplasma pneumoniae outbreak: Don't forget its role in Bickerstaff encephalitis.
- Author
-
Lacampagne T, Guillotin V, Peuchant O, Belloir A, Sibon I, Bébéar C, and Cazanave C
- Subjects
- Humans, Adolescent, Male, Disease Outbreaks, Anti-Bacterial Agents therapeutic use, Drug Resistance, Bacterial, Community-Acquired Infections microbiology, Community-Acquired Infections diagnosis, Community-Acquired Infections epidemiology, Macrolides therapeutic use, Mycoplasma pneumoniae isolation & purification, Mycoplasma pneumoniae genetics, Encephalitis microbiology, Encephalitis diagnosis, Pneumonia, Mycoplasma epidemiology, Pneumonia, Mycoplasma microbiology, Pneumonia, Mycoplasma diagnosis, Pneumonia, Mycoplasma drug therapy
- Abstract
Mycoplasma pneumoniae is a common cause of community-acquired pneumonia in children and young adults. It is responsible of a broad array of extrapulmonary manifestations, the most severe affecting the central nervous system. We report a challenging diagnosis of macrolide-resistant M. pneumoniae-induced Bickerstaff encephalitis in a 16-year-old man., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
3. Individual health insurance data of antibiotic delivery in previous months as a tool to predict bacterial resistance of urinary tract infection: A prospective cohort study.
- Author
-
Alexandre K, Gillibert A, Dahyot S, Fabre R, Kuhn F, Benichou J, Delbos V, and Caron F
- Subjects
- Humans, Prospective Studies, Female, Male, Middle Aged, Aged, Insurance, Health statistics & numerical data, France epidemiology, Community-Acquired Infections drug therapy, Community-Acquired Infections microbiology, Community-Acquired Infections epidemiology, Adult, Fosfomycin therapeutic use, Trimethoprim, Sulfamethoxazole Drug Combination therapeutic use, Cohort Studies, Aged, 80 and over, Amoxicillin-Potassium Clavulanate Combination therapeutic use, Urinary Tract Infections drug therapy, Urinary Tract Infections microbiology, Urinary Tract Infections epidemiology, Anti-Bacterial Agents therapeutic use, Escherichia coli drug effects, Escherichia coli isolation & purification, Drug Resistance, Bacterial, Escherichia coli Infections drug therapy, Escherichia coli Infections epidemiology
- Abstract
Objectives: We aimed to quantify the individual risk of antimicrobial resistance among patients with community-acquired Escherichia coli urinary tract infection (UTI) according to their antibiotic exposure over the previous 18 months., Patients and Methods: French patients were prospectively recruited in two centers in 2015-2017. Resistance of isolates to amoxicillin (AMX), amoxicillin-clavulanate (AMC), third-generation cephalosporins (3GC), trimethoprim-sulfamethoxazole (TMP-SMX), fluoroquinolones (FQ) and fosfomycin (FOS) was analysed according to previous intra-class and inter-class antibiotic exposure documented in health insurance files., Results: Previous antibiotic exposure was found in 588 (81.4 %) of the 722 UTI cases analysed (564 patients). Recent exposure (three months before UTI) was associated with stronger intra-class impact on E. coli resistance compared to remote exposure (18 months before UTI) for AMX, AMC, FQ and TMP-SMX, with respective adjusted odds ratios [95 % confidence interval] of 1.63 [1.20-2.21], 1.59 [1.02-2.48], 3.01 [1.90-4.77], and 2.60 [1.75-3.87]. AMX, FQ, and TMP-SMX also showed significant inter-class impact. Resistance to 3GC was not significantly associated with intraclass exposure (adjusted OR: 0.88 [0.41-1.90]). FOS resistance was remarkably low (0.4 %). Duration of the antibiotic-free period required for resistance risk to drop below 10 %, the threshold for empirical use in UTI, was modelled as < 1 month for 3GC, >18 months for AMX and TMP-SMX and uncertain for AMC (5.2 months [2.3 to > 18]) and FQ (17.4 months [7.4 to > 18])., Conclusions: Resistance of E. coli causing UTI is partially predicted by previous personal antibiotic delivery., (Copyright © 2024. Published by Elsevier Masson SAS.)
- Published
- 2024
- Full Text
- View/download PDF
4. Epidemiologic and Clinical Characteristics and Risk Factors for Severe Community-acquired Clostridium difficile Infection in Children.
- Author
-
Stemberger Marić L, Nikčević A, Bodulić K, and Tešović G
- Subjects
- Humans, Risk Factors, Child, Male, Female, Adolescent, Child, Preschool, Infant, Retrospective Studies, Community-Acquired Infections epidemiology, Community-Acquired Infections microbiology, Clostridium Infections epidemiology, Clostridioides difficile
- Abstract
Although children most frequently suffer from milder forms of community-acquired Clostridium difficile infection, severe cases and fatal outcomes have been recorded. In this study we identified older children (>12 years of age) and patients who had surgery up to 6 months before Clostridium difficile infection onset as a subgroup at somewhat higher risk for severe community-acquired Clostridium difficile infection., Competing Interests: The authors have no funding or conflicts of interest to disclose., (Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
5. Study of Empiric Antibiotic Prescription Patterns and Microbiological Isolates in Hemodynamically Stable and Unstable ICU Patients With Community-Acquired Sepsis.
- Author
-
Bhattacharyya M, Saha A, and Todi S
- Subjects
- Humans, Female, Male, Middle Aged, Aged, Adult, Hemodynamics drug effects, Hospital Mortality, Practice Patterns, Physicians' statistics & numerical data, Drug Therapy, Combination, Community-Acquired Infections drug therapy, Community-Acquired Infections microbiology, Community-Acquired Infections mortality, Anti-Bacterial Agents therapeutic use, Sepsis drug therapy, Sepsis microbiology, Sepsis mortality, Intensive Care Units statistics & numerical data
- Abstract
Background: The efficacy of combination empiric antibiotic therapy for all intensive care unit (ICU) patients with community-acquired sepsis is a subject of ongoing debate in the era of increasing antibiotic resistance. This study was conducted to evaluate the patterns of antibiotic usage and microbial resistance in sepsis patients admitted to the ICU with both hemodynamically stable (HS) and unstable states and to analyze their clinical outcomes. Methods: In this observational study, patients aged 18 years and above who received antibiotics upon admission and had a culture report were included. These patients were categorized into the following groups: HS and hemodynamically unstable (HU), single or combined antibiotics group (more than one antibiotic used empirically to cover one or more groups of organisms), culture-positive and culture-negative group. The microbiological isolates were grouped according to their identified resistance patterns. The outcome parameters involved assessing the differences in empiric antibiotics use upon admission and microbial resistance with hemodynamic stability and investigating any associations with ICU and hospital outcomes. Results: The study included a total of 2675 patients, of which 70.3% were in the HS group, and 29.7% in the HU group. The use of combination antibiotics was significantly higher ( p < 0 .0001) across all groups. Carbapenems were used more frequently in the single antibiotic group ( p < 0 .001). The culture was positive in 27.8% ( n = 747) of patients. A significantly higher number of patients in the HU group ( p < 0 .001) were found to have carbapenem-resistant and multidrug-resistant organisms. The ICU and hospital mortality rates were significantly higher in the HU group ( p < 0 .001), the culture-positive group with resistance ( p < 0 .001), and the HS patients who received combination antibiotics. Conclusion: The usage of combination antibiotics, coupled with the presence of resistant organisms, emerged as an important variable in predicting ICU and hospital mortality rates in cases of community-acquired sepsis., Competing Interests: Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2024
- Full Text
- View/download PDF
6. Characterization of bronchoalveolar lavage fluid microbiota in acute exacerbations of bronchiectasis with non-tuberculous mycobacterial detection.
- Author
-
Xu Q, Mei Z, Zha Q, Chen J, Qin H, Liu B, Jie Z, and Wu X
- Subjects
- Humans, Male, Female, Middle Aged, Aged, High-Throughput Nucleotide Sequencing, Community-Acquired Infections microbiology, Community-Acquired Infections diagnosis, Bronchiectasis microbiology, Bronchoalveolar Lavage Fluid microbiology, Microbiota, Nontuberculous Mycobacteria isolation & purification, Nontuberculous Mycobacteria genetics, Mycobacterium Infections, Nontuberculous microbiology, Mycobacterium Infections, Nontuberculous diagnosis
- Abstract
Objectives: Non-tuberculous mycobacteria (NTM) frequently colonize the airways of patients with bronchiectasis; however, there has been limited research into airway microbiota composition and predisposing factors for NTM detection during acute bronchiectasis exacerbations., Methods: This study enrolled 34 patients with bronchiectasis experiencing acute exacerbations. Metagenomic next-generation sequencing was used to detect microbiota in bronchoalveolar lavage fluid (BALF), and bioinformatics methods were used for the comparative analysis of meaningful microbiota in the BALF of patients with acute exacerbations of bronchiectasis. A correlation analysis was conducted to identify susceptibility factors for NTM in patients with bronchiectasis., Results: Compared with patients with community-acquired pneumonia, patients with bronchiectasis had higher detection rates of NTM (38.2%), Pseudomonas aeruginosa, and Haemophilus influenzae. Patients with NTM-positive bronchiectasis had lower body mass index and lipid profiles than patients who were NTM-negative. Metagenomic next-generation sequencing of BALF revealed patients who were NTM-positive had increased relative abundance of Rothia and other anaerobic genera compared with patients who were NTM-negative. Patients who were NTM-positive also showed higher levels of Streptococcus parasanguinis at the species level. Elevated Rothia mucilaginosa and S. parasanguinis correlated with decreased percentages of clusters of differentiation 3+ T lymphocytes and clusters of differentiation 3+ T-cell subgroups in peripheral blood., Conclusions: NTM colonization increases the risk of acute bronchiectasis exacerbations. Low body mass index, lipid levels, and isolation of R. mucilaginosa and S. parasanguinis in BALF are susceptibility factors for NTM colonization in patients with bronchiectasis., Competing Interests: Declarations of competing interest The authors have no competing interest to declare. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results., (Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
7. Multiplex real-time PCR in non-invasive respiratory samples to reduce antibiotic use in community-acquired pneumonia: a randomised trial.
- Author
-
Abelenda-Alonso G, Calatayud L, Rombauts A, Meije Y, Oriol I, Sopena N, Padullés A, Niubó J, Duarte A, Llaberia J, Aranda J, Gudiol C, Satorra P, Tebé C, Ardanuy C, and Carratalà J
- Subjects
- Humans, Female, Male, Aged, Middle Aged, Pneumonia drug therapy, Pneumonia microbiology, Pneumonia diagnosis, Real-Time Polymerase Chain Reaction methods, Nasopharynx microbiology, Spain, Community-Acquired Infections drug therapy, Community-Acquired Infections microbiology, Community-Acquired Infections diagnosis, Anti-Bacterial Agents therapeutic use, Multiplex Polymerase Chain Reaction methods, Sputum microbiology
- Abstract
We assessed whether multiplex real-time PCR plus conventional microbiological testing is safe and more effective than conventional microbiological testing alone for reducing antibiotic use in community-acquired pneumonia (CAP). In this randomised trial, we recruited adults hospitalised with CAP at four Spanish hospitals. Patients were randomly assigned (1:1) to undergo either multiplex real-time PCR in non-invasive respiratory samples plus conventional microbiological testing or conventional microbiological testing alone. The primary endpoint was antibiotic use measured by days of antibiotic therapy (DOT). Between February 20, 2020, and April 24, 2023, 242 patients were enrolled; 119 were randomly assigned to multiplex real-time PCR plus conventional microbiological testing and 123 to conventional microbiological testing alone. All but one of the patients allocated to multiplex real-time PCR plus conventional microbiological testing underwent PCR, which was performed in sputum samples in 77 patients (65.2%) and in nasopharyngeal swabs in 41 (34.7%). The median DOT was 10.04 (IQR 7.98, 12.94) in the multiplex PCR plus conventional microbiological testing group and 11.33 (IQR 8.15, 16.16) in the conventional microbiological testing alone group (difference -1.04; 95% CI, -2.42 to 0.17; p = 0.093). No differences were observed in adverse events and 30-day mortality. Our findings do not support the routine implementation of multiplex real-time PCR in the initial microbiological testing in hospitalised patients with CAP. Clinicaltrials.gov registration: NCT04158492., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
8. Epidemiological characteristics of mycoplasma pneumoniae in hospitalized children before, during, and after COVID-19 pandemic restrictions in Chongqing, China.
- Author
-
You J, Zhang L, Chen W, Wu Q, Zhang D, Luo Z, and Fu Z
- Subjects
- Humans, Child, Child, Preschool, China epidemiology, Female, Male, Infant, Adolescent, Retrospective Studies, Infant, Newborn, Prevalence, Hospitalization statistics & numerical data, Pandemics, Macrolides therapeutic use, Drug Resistance, Bacterial, Anti-Bacterial Agents therapeutic use, Anti-Bacterial Agents pharmacology, Child, Hospitalized statistics & numerical data, Seasons, Community-Acquired Infections epidemiology, Community-Acquired Infections microbiology, COVID-19 epidemiology, Pneumonia, Mycoplasma epidemiology, Mycoplasma pneumoniae drug effects, Mycoplasma pneumoniae isolation & purification, SARS-CoV-2 isolation & purification
- Abstract
Background: Mycoplasma pneumoniae (MP) is a significant cause of community-acquired pneumonia with high macrolide resistance rates. Various COVID-19 pandemic restrictions have impacted the prevalence of MP., Objective: To assess the changes in the pattern of MP infections among children before, during, and after the COVID-19 pandemic., Methods: A total of 36685 enrolled patients, aged 0-18 years, diagnosed with pneumonia and admitted to Children's Hospital of Chongqing Medical University from January 2019 to December 2023, were retrospectively reviewed in this study. The epidemiological characteristics of pediatric MP infection were analyzed., Results: Among 36685 patients, 7610 (20.74%) tested positive for MP. The highest positive rate was observed among children aged over 6 years (55.06%). There was no gender disparity in MP infection across the three phases of the COVID-19 pandemic. Hospital stays were longest for children during the COVID-19 pandemic ( P <0.001). MP infection was most prevalent in the summer (29.64%). The lowest positive rate was observed during the pandemic, with the highest rate found after easing the measures across all age groups ( P <0.001). There was a surge in the positive rate of MP in the third year after the COVID-19 pandemic. Regression analyses demonstrated a shift in the age range susceptible to MP infection, with children aged 3.8 to 13.5 years post-pandemic compared to the pre-pandemic range of 5.3 to 15.5 years old. Additionally, the average macrolide resistance rate was 79.84%. We observed a higher resistance rate during the pandemic than in the pre- and post-pandemic phases ( P <0.001)., Conclusion: The restrictive measures implemented during the COVID-19 pandemic have influenced the spread of MP to some extent and altered demographic and clinical characteristics, such as age, age group, season, length of stay, and macrolide resistance. We recommend continuous surveillance of the evolving epidemiological characteristics of MP infection in the post-pandemic period when restrictions are no longer necessary., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2024 You, Zhang, Chen, Wu, Zhang, Luo and Fu.)
- Published
- 2024
- Full Text
- View/download PDF
9. Otitis in Patients With Community-Acquired Bacterial Meningitis: A Nationwide Prospective Cohort Study.
- Author
-
Ranzenigo M, van Soest TM, Hensen EF, Cinque P, Castagna A, Brouwer MC, and van de Beek D
- Subjects
- Humans, Male, Female, Prospective Studies, Netherlands epidemiology, Middle Aged, Aged, Adult, Otitis microbiology, Otitis epidemiology, Otitis surgery, Streptococcus pneumoniae isolation & purification, Streptococcus pyogenes isolation & purification, Haemophilus influenzae isolation & purification, Mastoidectomy, Young Adult, Aged, 80 and over, Community-Acquired Infections microbiology, Community-Acquired Infections epidemiology, Meningitis, Bacterial epidemiology, Meningitis, Bacterial microbiology, Meningitis, Bacterial mortality
- Abstract
Background: Otitis is commonly associated with community-acquired bacterial meningitis, but the role of ear surgery as treatment is debated. In this study, we investigated the impact of otitis and ear surgery on outcome of adults with community-acquired bacterial meningitis., Methods: We analyzed episodes of adults with community-acquired bacterial meningitis from a nationwide prospective cohort study in the Netherlands, between March 2006 and July 2021., Results: A total of 2548 episodes of community-acquired bacterial meningitis were evaluated. Otitis was present in 696 episodes (27%). In these patients the primary causative pathogen was Streptococcus pneumoniae (615 of 696 [88%]), followed by Streptococcus pyogenes (5%) and Haemophilus influenzae (4%). In 519 of 632 otitis episodes (82%) an ear-nose-throat specialist was consulted, and surgery was performed in 287 of 519 (55%). The types of surgery performed were myringotomy with ventilation tube insertion in 110 of 287 episodes (38%), mastoidectomy in 103 of 287 (36%), and myringotomy alone in 74 of 287 (26%). Unfavorable outcome occurred in 210 of 696 episodes (30%) and in 65 of 696 episodes was fatal (9%). Otitis was associated with a favorable outcome in a multivariable analysis (odds ratio 0.74; 95% confidence interval [CI] .59-.92; P = .008). There was no association between outcome and ear surgery., Conclusions: Otitis is a common focus of infection in community-acquired bacterial meningitis in adults, with S. pneumoniae being the most common causative pathogen. Presence of otitis is associated with a favorable outcome. Ear surgery's impact on the outcome of otogenic meningitis patients remains uncertain., Competing Interests: Potential conflicts of interest. The authors: No reported conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed., (© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.)
- Published
- 2024
- Full Text
- View/download PDF
10. Combinatorial Host-Response Biomarker Signature (BV Score) and Its Subanalytes TRAIL, IP-10, and C-Reactive Protein in Children With Mycoplasma pneumoniae Community-Acquired Pneumonia.
- Author
-
Papan C, Sidorov S, Greiter B, Bühler N, Berger C, Becker SL, and Meyer Sauteur PM
- Subjects
- Humans, Male, Female, Child, Child, Preschool, Infant, Adolescent, Pneumonia, Mycoplasma blood, Pneumonia, Mycoplasma diagnosis, Pneumonia, Mycoplasma microbiology, Chemokine CXCL10 blood, Community-Acquired Infections blood, Community-Acquired Infections microbiology, Community-Acquired Infections diagnosis, TNF-Related Apoptosis-Inducing Ligand blood, Biomarkers blood, C-Reactive Protein analysis, C-Reactive Protein metabolism, Mycoplasma pneumoniae, ROC Curve
- Abstract
Background: Host-response biomarkers to differentiate bacterial from viral etiology in children with respiratory infections have shown high accuracies, but are understudied in Mycoplasma pneumoniae (Mp) infections., Methods: We compared BV scores (0-34 indicating viral etiology, and 66-100 indicating bacterial etiology), tumor necrosis factor-related apoptosis-inducing ligand (TRAIL; pg/mL), interferon-γ inducible protein 10 (IP-10; pg/mL), and C-reactive protein (CRP; mg/L) serum levels between Mp-positive (Mp+) and Mp-negative (Mp-) community-acquired pneumonia (CAP) patients. We performed receiver operating characteristic (ROC) curve analyses for clinical features and biomarkers., Results: Of 80 CAP patients (median age, 6.3 years; 57.5% male), 26 had Mp+CAP. In Mp+CAP patients, compared to Mp-CAP patients, BV scores were lower (14.0 [3.0-27.8] vs 54.0 [12.0-84.8]; P = .0008), TRAIL levels were higher (86.5 [67.4-123.0] vs 65.5 [42.5-103.9]; P = .025), CRP levels were lower (12.9 [4.0-22.3] vs 36.7 [13.0-132.8]; P = .0019), and IP-10 levels were comparable (366.0 [150.2-603.8] vs 331.0 [154.3-878.8]; P = .73) (all median [interquartile range]). ROC analyses yielded a comparable discriminatory accuracy for the combination of age, fever duration, and duration of respiratory symptoms, with either procalcitonin or BV score (area under the ROC curve, 0.87 vs 0.86; P = .94)., Conclusions: Children with Mp+CAP have atypically low, viral levels of the BV score, underscoring the complementary role of microbiological testing., Competing Interests: Potential conflicts of interest . All authors: No reported conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed., (© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.)
- Published
- 2024
- Full Text
- View/download PDF
11. Diabetic Patient with CA-MRSA Pneumonia and Plasma Cell Neoplasm: A Case Report of Severe Complications and Prognosis.
- Author
-
Al-Mattar MA, Al-Zaher M, Al-Salman JS, Mohamed ZSA, Marhoon AZ, and Al-Ghasra Z
- Subjects
- Humans, Male, Pneumonia, Staphylococcal, Prognosis, Middle Aged, Fractures, Spontaneous etiology, Community-Acquired Infections microbiology, Diabetes Complications, Methicillin-Resistant Staphylococcus aureus
- Abstract
BACKGROUND The prevalence of methicillin-resistant Staphylococcus aureus (MRSA) has been increasing in recent years, becoming a cause of community-acquired infection. Interestingly, its role in malignancy recently started to be considered after a noticed increase in reported cases and studies discussing the potential association. CASE REPORT In the present case, the patient had known and uncontrolled diabetes mellitus and a history of multiple abscesses that were previously treated by incision and drainage. The patient received a diagnosis of severe pneumonia, and MRSA was found in blood cultures. Further tests for HIV, hemagglutinin type 1, and neuraminidase type 1 (H1N1) were negative. The D test was also performed for macrolide-inducible resistance and was negative, indicating the need for intravenous administration of clindamycin. An echocardiogram ruled out endocarditis. Subsequently, the patient experienced progressive back pain and weakness involving the lower limbs. A pathological fracture was discovered, along with nerve root compression. An urgent posterior spine fixation was then performed by a neurosurgeon. A biopsy was collected at the site of the pathological fracture, and histopathological tests indicated a plasma cell neoplasm. CONCLUSIONS MRSA is known to cause serious and dangerous infections, including necrotizing pneumonia. Furthermore, a link between MRSA and plasma cell dyscrasia has been considered in several reports. This necessitates the need for further studies to clarify this hidden association, which may help in the course and prognosis of these patients.
- Published
- 2024
- Full Text
- View/download PDF
12. Dynamical analysis of methicillin-resistant Staphylococcus aureus infection in North Cyprus with optimal control: prevalence and awareness.
- Author
-
Gokbulut N, Farman M, Hurdoganoglu U, Sultanoglu N, Guler E, Hincal E, and Suer K
- Subjects
- Humans, Prevalence, Cyprus epidemiology, Community-Acquired Infections prevention & control, Community-Acquired Infections epidemiology, Community-Acquired Infections microbiology, Community-Acquired Infections transmission, Awareness, Models, Theoretical, Hand Hygiene, Methicillin-Resistant Staphylococcus aureus isolation & purification, Staphylococcal Infections epidemiology, Staphylococcal Infections prevention & control, Staphylococcal Infections microbiology, Cross Infection prevention & control, Cross Infection epidemiology, Cross Infection microbiology
- Abstract
The number of Methicillin-resistant Staphylococcus aureus (MRSA) cases in communities and hospitals is on the rise worldwide. In this work, a nonlinear deterministic model for the dynamics of MRSA infection in society was developed to visualize the significance of awareness in interventions that could be applied in the prevention of transmission with and without optimal control. Positivity and uniqueness were verified for the proposed corruption model to identify the level of resolution of infection factors in society. Furthermore, how various parameters affect the reproductive number R 0 and sensitivity analysis of the proposed model was explored through mathematical techniques and figures. The global stability of model equilibria analysis was established by using Lyapunov functions with the first derivative test. A total of seven years of data gathered from a private hospital consisting of inpatients and outpatients of MRSA were used in this model for numerical simulations and for observing the dynamics of infection by using a non-standard finite difference (NSFD) scheme. When optimal control was applied as a second model, it was determined that increasing awareness of hand hygiene and wearing a mask were the key controlling measures to prevent the spread of community-acquired MRSA (CA-MRSA) and hospital-acquired MRSA (HA-MRSA). Lastly, it was concluded that both CA-MRSA and HA-MRSA cases are on the rise in the community, and increasing awareness concerning transmission is extremely significant in preventing further spread., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
13. Application of metagenomic next-generation sequencing and targeted metagenomic next-generation sequencing in diagnosing pulmonary infections in immunocompetent and immunocompromised patients.
- Author
-
Liu Y, Wu W, Xiao Y, Zou H, Hao S, and Jiang Y
- Subjects
- Humans, Male, Female, Middle Aged, China, Adult, Aged, Young Adult, Bacteria genetics, Bacteria isolation & purification, Bacteria classification, Sputum microbiology, Sputum virology, Community-Acquired Infections diagnosis, Community-Acquired Infections microbiology, Community-Acquired Infections virology, Adolescent, Immunocompetence, Pneumonia diagnosis, Pneumonia microbiology, Pneumonia virology, Aged, 80 and over, Immunocompromised Host, High-Throughput Nucleotide Sequencing methods, Metagenomics methods, Bronchoalveolar Lavage Fluid microbiology, Bronchoalveolar Lavage Fluid virology
- Abstract
Background: Metagenomic next-generation sequencing (mNGS) technology has been widely used to diagnose various infections. Based on the most common pathogen profiles, targeted mNGS (tNGS) using multiplex PCR has been developed to detect pathogens with predesigned primers in the panel, significantly improving sensitivity and reducing economic burden on patients. However, there are few studies on summarizing pathogen profiles of pulmonary infections in immunocompetent and immunocompromised patients in Jilin Province of China on large scale., Methods: From January 2021 to December 2023, bronchoalveolar lavage fluid (BALF) or sputum samples from 546 immunocompetent and immunocompromised patients with suspected community-acquired pneumonia were collected. Pathogen profiles in those patients on whom mNGS was performed were summarized. Additionally, we also evaluated the performance of tNGS in diagnosing pulmonary infections., Results: Combined with results of mNGS and culture, we found that the most common bacterial pathogens were Pseudomonas aeruginosa , Klebsiella pneumoniae , and Acinetobacter baumannii in both immunocompromised and immunocompetent patients with high detection rates of Staphylococcus aureus and Enterococcus faecium , respectively. For fungal pathogens, Pneumocystis jirovecii was commonly detected in patients, while fungal infections in immunocompetent patients were mainly caused by Candida albicans . Most of viral infections in patients were caused by Human betaherpesvirus 5 and Human gammaherpesvirus 4. It is worth noting that, compared with immunocompetent patients (34.9%, 76/218), more mixed infections were found in immunocompromised patients (37.8%, 14/37). Additionally, taking final comprehensive clinical diagnoses as reference standard, total coincidence rate of BALF tNGS (81.4%, 48/59) was much higher than that of BALF mNGS (40.0%, 112/280)., Conclusions: Our findings supplemented and classified the pathogen profiles of pulmonary infections in immunocompetent and immunocompromised patients in Jilin Province of China. Most importantly, our findings can accelerate the development and design of tNGS specifically used for regional pulmonary infections., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2024 Liu, Wu, Xiao, Zou, Hao and Jiang.)
- Published
- 2024
- Full Text
- View/download PDF
14. Incidence of drug-resistant pathogens in community-acquired pneumonia at a safety net hospital.
- Author
-
Ding H, Mang NS, Loomis J, Ortwine JK, Wei W, O'Connell EJ, Shah NJ, and Prokesch BC
- Subjects
- Humans, Retrospective Studies, Male, Female, Incidence, Aged, Middle Aged, Risk Factors, Aged, 80 and over, Drug Resistance, Bacterial, Pneumonia microbiology, Pneumonia drug therapy, Pneumonia epidemiology, Pseudomonas Infections epidemiology, Pseudomonas Infections microbiology, Pseudomonas Infections drug therapy, Adult, Staphylococcal Infections epidemiology, Staphylococcal Infections microbiology, Staphylococcal Infections drug therapy, Community-Acquired Infections microbiology, Community-Acquired Infections epidemiology, Community-Acquired Infections drug therapy, Methicillin-Resistant Staphylococcus aureus drug effects, Methicillin-Resistant Staphylococcus aureus isolation & purification, Pseudomonas aeruginosa drug effects, Pseudomonas aeruginosa isolation & purification, Anti-Bacterial Agents pharmacology, Anti-Bacterial Agents therapeutic use
- Abstract
The 2019 Infectious Diseases Society of America guideline for the management of community-acquired pneumonia (CAP) emphasizes the need for clinician to understand local epidemiological data to guide selection of appropriate treatment. Currently, the local distribution of causative pathogens and their associated resistance patterns in CAP is unknown. A retrospective observational study was performed of patients admitted to an 870-bed safety net hospital between March 2016 and March 2021 who received a diagnosis of CAP or healthcare-associated pneumonia within the first 48 hours of admission. The primary outcome was the incidence of CAP caused by methicillin-resistant Staphylococcus aureus (MRSA) or Pseudomonas aeruginosa (PsA) as determined by comparing the number of satisfactory sputum cultures or blood cultures with these drug-resistant organisms to the total number of reviewed patients. Secondary outcomes studied included risk factors associated with CAP caused by drug-resistant organisms, utilization of broad-spectrum antibiotics, appropriate antibiotic de-escalation within 72 hours, and treatment duration. In this 220-patient cohort, MRSA or PsA was isolated from three sputum cultures and no blood cultures. The local incidence of drug-resistant pathogens among the analyzed sample of CAP patients was 1.4% ( n = 3/220). The overall incidence of CAP caused by MRSA or PsA among admitted patients is low at our safety-net county hospital. Future research is needed to identify local risk factors associated with the development of CAP caused by drug-resistant pathogens.IMPORTANCEThis study investigates the incidence of drug-resistant pathogens including methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa among community-acquired pneumonia (CAP) patients at a safety net hospital. Understanding local bacteria resistance patterns when treating CAP is essential and supported by evidence-based guidelines. Our findings empower other clinicians to investigate resistance patterns at their own institutions and identify methods to improve antibiotic use. This has the potential to reduce the unnecessary use of broad-spectrum antibiotic agents and combat the development of antibiotic resistance., Competing Interests: The authors declare no conflict of interest.
- Published
- 2024
- Full Text
- View/download PDF
15. [Clinical profiles of community-acquired Pseudomonas aeruginosa infections in children].
- Author
-
Qiu Y, Lin DJ, Xi JN, Xu Y, Shan QW, Zhu CH, Cheng YB, Wang F, Chen YP, and Zeng M
- Subjects
- Humans, Male, Female, Retrospective Studies, Child, Preschool, Infant, China epidemiology, Microbial Sensitivity Tests, Child, Drug Resistance, Multiple, Bacterial, Tertiary Care Centers, Community-Acquired Infections microbiology, Community-Acquired Infections drug therapy, Community-Acquired Infections epidemiology, Pseudomonas aeruginosa isolation & purification, Pseudomonas aeruginosa drug effects, Pseudomonas Infections drug therapy, Pseudomonas Infections epidemiology, Pseudomonas Infections microbiology, Anti-Bacterial Agents therapeutic use
- Abstract
Objectives: To investigate clinical characteristics, outcomes and antimicrobial resistance of community-acquired Pseudomonas aeruginosa (CAPA) infections in Chinese pediatric patients. Methods: This retrospective study was conducted at 6 tertiary hospitals in China during January 2016 to December 2018. The clinical and microbiological data of CAPA infected hospitalized children in Hainan and in other regions were collected and compared, and the antimicrobial resistance patterns, clinical characteristics and antibiotic therapy were analyzed. Between different groups were compared using the Chi-square test and Mann-Whitney U test. Results: Among 91 patients, 63 cases were males, 28 cases were females, and 74 cases were from Hainan province, 17 cases were from other regians. The age of consultation was 22.5 (5.4, 44.0) months. Twenty-four cases (26%) had underlying diseases. Fever (79 cases (87%)) and cough (64 cases (70%)) were common initial symptoms. Other concomitant symptoms included wheezing 8 cases (9%), diarrhea 3 cases (3%) and vomiting 4 cases (4%). Twenty-eight cases (31%) had organ infections, including pneumonia 22 cases (24%), skin infection 5 cases (5%), meningitis, intra-abdominal infection and upper urinary tract infection each 1 case (1%). The resistance rate of CAPA isolates to cefepime (4% (4/90)), amikacin (1% (1/90)), ciprofloxacin (2% (2/90)) and levofloxacin (1% (1/89)) was low, and to ceftazidime, piperacillin, piperacillin-azobactam, carbapenem was 12% (11/90), 3/16, 18% (10/56) and 6% (5/90), respectively. Antimicrobial combination therapy accounted for 52% (47/91) of empirical therapy and 59% (52/88) of definite therapy. Two cases (2%) were hopeless discharged, and 3 cases (3%) died during hospitalization. The worse prognosis of CAPA infection is significantly different among children in other regions and in Hainan (4/17 vs. 1% (1/74), χ ²=9.74, P <0.05). Conclusions: The invasive CAPA-infection has regional difference in incidence and prognosis in China. Clinical symptoms and signs are non-specific. CAPA strains isolated from pediatric patients display low level of resistance to most of the common antipseudomonal antibiotics. The proportion of poor prognostic outcome is lower in Hainan than in other regions.
- Published
- 2024
- Full Text
- View/download PDF
16. The Epidemiology of Pathogens in Community-Acquired Pneumonia Among Children in Southwest China Before, During and After COVID-19 Non-pharmaceutical Interventions: A Cross-Sectional Study.
- Author
-
Yang R, Xu H, Zhang Z, Liu Q, Zhao R, Zheng G, and Wu X
- Subjects
- Humans, China epidemiology, Cross-Sectional Studies, Child, Preschool, Female, Male, Child, Infant, SARS-CoV-2 isolation & purification, SARS-CoV-2 genetics, Mycoplasma pneumoniae isolation & purification, Mycoplasma pneumoniae genetics, Adolescent, Pneumonia epidemiology, Pneumonia microbiology, Pneumonia virology, Community-Acquired Infections epidemiology, Community-Acquired Infections microbiology, Community-Acquired Infections virology, COVID-19 epidemiology
- Abstract
Objective: This study aimed to investigate the pathogen epidemiology of community-acquired pneumonia (CAP) among children in Southwest China before, during and after the COVID-19 non-pharmaceutical interventions (NPIs)., Methods: Pathogen data of hospitalised children with CAP, including multiple direct immunofluorescence test for seven viruses, bacterial culture and polymerase chain reaction (PCR) for Mycoplasma pneumoniae, were analysed across three phases: Phase I (pre-NPIs: 1 January 2019 to 31 December 2019), Phase II (NPI period: 1 January 2020 to 31 December 2020) and Phase III (post-NPIs: 1 January 2023 to 31 December 2023)., Results: A total of 7533 cases were enrolled, including 2444, 1642 and 3447 individuals in Phases I, II and III, respectively. M. pneumoniae predominated in Phases I and III (23.4% and 35.5%, respectively). In Phase II, respiratory syncytial virus (RSV) emerged as the primary pathogen (20.3%), whereas detection rates of influenza A virus (Flu A) and M. pneumoniae were at a low level (1.8% and 9.6%, respectively). In Phase III, both Flu A (15.8%) and M. pneumoniae epidemic rebounded, whereas RSV detection rate returned to Phase I level, and detection rates of Streptococcus pneumoniae and Haemophilus influenzae decreased significantly compared to those in Phase I. Detection rates of adenovirus and parainfluenza virus type 3 decreased phase by phase. Age-stratified analysis and monthly variations supported the above findings. Seasonal patterns of multiple pathogens were disrupted during Phases II and III., Conclusions: COVID-19 NPIs exhibited a distinct impact on CAP pathogen epidemic among children, with post-NPIs increases observed in M. pneumoniae and Flu A prevalence. Continuous pathogen monitoring is crucial for effective prevention and control of paediatric CAP., (© 2024 The Author(s). Influenza and Other Respiratory Viruses published by John Wiley & Sons Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
17. A review of the value of point-of-care testing for community-acquired pneumonia.
- Author
-
Palomeque A, Cilloniz C, Soler-Comas A, Canseco-Ribas J, Rovira-Ribalta N, Motos A, and Torres A
- Subjects
- Humans, Streptococcus pneumoniae isolation & purification, Molecular Diagnostic Techniques methods, Anti-Bacterial Agents therapeutic use, Sputum microbiology, Community-Acquired Infections diagnosis, Community-Acquired Infections microbiology, Point-of-Care Testing, Pneumonia diagnosis, Pneumonia microbiology
- Abstract
Introduction: Community-acquired pneumonia (CAP) is an infectious disease associated with high mortality worldwide. Although Streptococcus pneumoniae remains the most frequent pathogen in CAP, data from recent studies using molecular tests have shown that respiratory viruses play a key role in adults with pneumonia. The impact of difficult-to-treat pathogens on the outcomes of pneumonia is also important even though they represent only a small proportion of overall cases. Despite improvements in the microbiological diagnosis of CAP in recent decades, the identification of the causative pathogen is often delayed because of difficulties in obtaining good-quality sputum samples, issues in transporting samples, and slow laboratory processes. Therefore, the initial treatment of CAP is usually empirical. Point-of-care testing (POCT) was introduced to avoid treatment delays and reduce reliance on empirical antibiotics., Areas Covered: This review summarizes the main scientific evidence on the role of POCT in the diagnosis and management of patients with CAP. The authors searched for articles on POCT in pneumonia on PubMed from inception to 20 January 2024. The references in the identified articles were also searched., Expert Opinion: POCT involves rapid diagnostic assays that can be performed at the bedside especially in cases of severe CAP and immunocompromised patients. These tests can produce results that could help guide initial therapy and management.
- Published
- 2024
- Full Text
- View/download PDF
18. Global Case Fatality of Bacterial Meningitis During an 80-Year Period: A Systematic Review and Meta-Analysis.
- Author
-
van Ettekoven CN, Liechti FD, Brouwer MC, Bijlsma MW, and van de Beek D
- Subjects
- Humans, Global Health statistics & numerical data, Community-Acquired Infections mortality, Community-Acquired Infections microbiology, Female, Male, Risk Factors, Adult, Meningitis, Bacterial mortality, Meningitis, Bacterial epidemiology
- Abstract
Importance: The impact of vaccination, antibiotics, and anti-inflammatory treatment on pathogen distribution and outcome of bacterial meningitis over the past century is uncertain., Objective: To describe worldwide pathogen distribution and case fatality ratios of community-acquired bacterial meningitis., Data Sources: Google Scholar and MEDLINE were searched in January 2022 using the search terms bacterial meningitis and mortality., Study Selection: Included studies reported at least 10 patients with bacterial meningitis and survival status. Studies that selected participants by a specific risk factor, had a mean observation period before 1940, or had more than 10% of patients with health care-associated meningitis, tuberculous meningitis, or missing outcome were excluded., Data Extraction and Synthesis: Data were extracted by 1 author and verified by a second author. The study followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses. Random-effects models stratified by age (ie, neonates, children, adults), Human Development Index (ie, low-income or high-income countries), and decade and meta-regression using the study period's year as an estimator variable were used., Main Outcome and Measure: Case fatality ratios of bacterial meningitis., Results: This review included 371 studies performed in 108 countries from January 1, 1935, to December 31, 2019, describing 157 656 episodes. Of the 33 295 episodes for which the patients' sex was reported, 13 452 (40%) occurred in females. Causative pathogens were reported in 104 598 episodes with Neisseria meningitidis in 26 344 (25%) episodes, Streptococcus pneumoniae in 26 035 (25%) episodes, Haemophilus influenzae in 22 722 (22%), other bacteria in 19 161 (18%) episodes, and unidentified pathogen in 10 336 (10%) episodes. The overall case fatality ratio was 18% (95% CI, 16%-19%), decreasing from 32% (95% CI, 24%-40%) before 1961 to 15% (95% CI, 12%-19%) after 2010. It was highest in meningitis caused by Listeria monocytogenes at 27% (95% CI, 24%-31%) and pneumococci at 24% (95% CI, 22%-26%), compared with meningitis caused by meningococci at 9% (95% CI, 8%-10%) or H influenzae at 11% (95% CI, 10%-13%). Meta-regression showed decreasing case fatality ratios overall and stratified by S pneumoniae, Escherichia coli, or Streptococcus agalactiae (P < .001)., Conclusions and Relevance: In this meta-analysis with meta-regression, declining case fatality ratios of community-acquired bacterial meningitis throughout the last century were observed, but a high burden of disease remained.
- Published
- 2024
- Full Text
- View/download PDF
19. Pertussis in infants: Alarm lights and amplifiers for persistent community transmission.
- Author
-
Meng Q, Shi W, Hu Y, and Yao K
- Subjects
- Humans, Infant, Community-Acquired Infections transmission, Community-Acquired Infections microbiology, Infant, Newborn, Whooping Cough transmission
- Abstract
Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
- Published
- 2024
- Full Text
- View/download PDF
20. Comment on: Community-acquired pneumonia: a US perspective on the guideline gap.
- Author
-
Llor C
- Subjects
- Humans, United States, Pneumonia drug therapy, Anti-Bacterial Agents therapeutic use, Guideline Adherence, Community-Acquired Infections microbiology, Practice Guidelines as Topic
- Published
- 2024
- Full Text
- View/download PDF
21. Comment on: Community-acquired pneumonia: a US perspective on the guideline gap.
- Author
-
Tillotson GS
- Subjects
- Humans, United States, Pneumonia drug therapy, Anti-Bacterial Agents therapeutic use, Guideline Adherence, Community-Acquired Infections microbiology, Practice Guidelines as Topic
- Published
- 2024
- Full Text
- View/download PDF
22. Diagnostic Accuracy of Blind Bronchial Sample Testing by BioFire Pneumonia plus Panel in Pediatric Intensive Care Unit Patients and Its Impact in Early Adaptation of Antimicrobial Therapy: A Prospective Observational Study.
- Author
-
Geslain G, Cointe A, Naudin J, Dauger S, Poey N, Pages J, Le Roux E, and Bonacorsi S
- Subjects
- Humans, Prospective Studies, Male, Female, Infant, Child, Preschool, Child, Community-Acquired Infections drug therapy, Community-Acquired Infections diagnosis, Community-Acquired Infections microbiology, Bronchi microbiology, Pneumonia, Ventilator-Associated drug therapy, Pneumonia, Ventilator-Associated diagnosis, Pneumonia, Ventilator-Associated microbiology, Microbial Sensitivity Tests, Adolescent, Multiplex Polymerase Chain Reaction methods, Intensive Care Units, Pediatric, Anti-Bacterial Agents therapeutic use, Sensitivity and Specificity
- Abstract
Background: Community-acquired and nosocomial lower-respiratory-tract infections in critically ill pediatric patients require early appropriate antibiotic therapy to optimize outcomes. Using blind bronchial samples, we assessed the diagnostic performance of the rapid-multiplex polymerase chain reaction (PCR) assay BioFire Pneumonia plus Panel vs. reference standard culturing with antimicrobial susceptibility testing., Methods: For this prospective observational study in a single pediatric intensive care unit, we included consecutive patients younger than 18 years admitted for suspected community-, hospital- or ventilator-associated pneumonia in 2021-2022. Sensitivity, specificity, positive predictive value and negative predictive value of the multiplex PCR assay were determined. The kappa coefficient was computed to assess agreement, and univariate analyses were done to identify factors associated with discrepancies between the 2 diagnostic methods., Results: Of the 36 included patients (median age, 1.4 years; interquartile range, 0.2-9.2), 41.7%, 27.8%, and 30.5% had community-, hospital- and ventilator-associated pneumonia, respectively. The overall κ was 0.74, indicating good agreement. Overall, the sensitivity of the multiplex PCR assay was 92% (95% CI: 77%-98%) and specificity 95% (95% CI: 92%-97%), with variations across microorganisms. The median time from sample collection to antimicrobial susceptibility test results was 3.9 (2.5-15) hours with the multiplex PCR assay and 60.5 (47.6-72.2) hours with the reference technique., Conclusion: The BioFire Pneumonia plus Panel used to test blind bronchial samples had satisfactory diagnostic performance in critically ill pediatric patients. The rapid results provided by this test may improve the appropriateness of antimicrobial therapy and help minimize the use of antibiotics., Competing Interests: Biomérieux support GG for attending meetings and travel. Other authors have no funding or conflicts of interest to disclose., (Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
23. Development of a score model to predict long-term prognosis after community-onset pneumonia in older patients.
- Author
-
Takazono T, Namie H, Nagayoshi Y, Imamura Y, Ito Y, Sumiyoshi M, Ashizawa N, Yoshida M, Takeda K, Iwanaga N, Ide S, Harada Y, Hosogaya N, Takemoto S, Fukuda Y, Yamamoto K, Miyazaki T, Sakamoto N, Obase Y, Sawai T, Higashiyama Y, Hashiguchi K, Funakoshi S, Suyama N, Tanaka H, Yanagihara K, Izumikawa K, and Mukae H
- Subjects
- Humans, Female, Male, Prognosis, Aged, Aged, 80 and over, Prospective Studies, Risk Factors, Anti-Bacterial Agents therapeutic use, Predictive Value of Tests, Dementia diagnosis, Dementia epidemiology, Community-Acquired Infections microbiology, Community-Acquired Infections diagnosis, Community-Acquired Infections drug therapy, Pneumonia diagnosis, Pneumonia microbiology, Pneumonia drug therapy, Pneumonia mortality
- Abstract
Background and Objective: The identification of factors associated with long-term prognosis after community-onset pneumonia in elderly patients should be considered when initiating advance care planning (ACP). We aimed to identify these factors and develop a prediction score model., Methods: Patients aged 65 years and older, who were hospitalized for pneumonia at nine collaborating institutions, were included. The prognosis of patients 180 days after the completion of antimicrobial treatment for pneumonia was prospectively collected., Results: The total number of analysable cases was 399, excluding 7 outliers and 42 cases with missing data or unknown prognosis. These cases were randomly divided in an 8:2 ratio for score development and testing. The median age was 82 years, and there were 68 (17%) deaths. A multivariate analysis showed that significant factors were performance status (PS) ≥2 (Odds ratio [OR], 11.78), hypoalbuminemia ≤2.5 g/dL (OR, 5.28) and dementia (OR, 3.15), while age and detection of antimicrobial-resistant bacteria were not associated with prognosis. A scoring model was then developed with PS ≥2, Alb ≤2.5, and dementia providing scores of 2, 1 and 1 each, respectively, for a total of 4. The area under the curve was 0.8504, and the sensitivity and specificity were 94.6% and 61.7% at the cutoff of 2, respectively. In the test cases, the sensitivity and specificity were 91.7% and 63.1%, respectively, at a cutoff value of 2., Conclusion: Patients meeting this score should be considered near the end of life, and the initiation of ACP practices should be considered., (© 2024 Asian Pacific Society of Respirology.)
- Published
- 2024
- Full Text
- View/download PDF
24. Disease burden and macrolide resistance of Mycoplasma pneumoniae infection in adults in the Asia-Pacific region.
- Author
-
Chih-Cheng Lai, Hsueh CC, Hsu CK, Tsai YW, and Hsueh PR
- Subjects
- Humans, Asia epidemiology, Community-Acquired Infections microbiology, Community-Acquired Infections epidemiology, Community-Acquired Infections drug therapy, Adult, Prevalence, Cost of Illness, Mycoplasma pneumoniae drug effects, Mycoplasma pneumoniae genetics, Macrolides therapeutic use, Macrolides pharmacology, Pneumonia, Mycoplasma epidemiology, Pneumonia, Mycoplasma microbiology, Pneumonia, Mycoplasma drug therapy, Anti-Bacterial Agents pharmacology, Anti-Bacterial Agents therapeutic use, Drug Resistance, Bacterial
- Abstract
Objectives: In the Asia-Pacific region, Mycoplasma pneumoniae (MP) could be a notable pathogen responsible for adult community-acquired pneumonia (CAP), with varying prevalence rates. This comprehensive review aimed to explore the epidemiology, clinical manifestations, macrolide resistance, and molecular characteristics of MP in adults across several countries in Asia., Methods: PubMed, Embase, and Google Scholar were searched for relevant articles from 2010-2023 based on the following keywords: adult and Mycoplasma pneumoniae., Results: The prevalence of MP in CAP patients in these countries ranged from 2.1% in Korea to 25.5% in Japan. Macrolide resistance was prominent, particularly in China, with rates ranging 26.9-100%. Clinical manifestations of MP infection included protean extrapulmonary manifestations, and complications such as rhabdomyolysis and thrombocytopenia. Molecular characteristics, especially the multiple locus variable-number tandem-repeat analysis type 4/5/7/2, remained predominant across various countries, emphasising the importance of ongoing surveillance., Conclusions: This review highlights the urgent need for continued monitoring of MP infections, macrolide resistance, and molecular characteristics to inform effective prevention and treatment strategies in the Asia-Pacific region., (Copyright © 2024 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
25. Pseudomonas stutzeri bloodstream infection is a prevailing community-onset disease with important mortality rates: results from a retrospective observational study in Australia.
- Author
-
Horcajada JP, Edwards F, Fonio S, Montero M, Harris P, Paterson DL, and Laupland KB
- Subjects
- Humans, Retrospective Studies, Male, Female, Middle Aged, Aged, Incidence, Adult, Queensland epidemiology, Aged, 80 and over, Cross Infection mortality, Cross Infection epidemiology, Cross Infection microbiology, Young Adult, Adolescent, Anti-Bacterial Agents therapeutic use, Community-Acquired Infections microbiology, Community-Acquired Infections mortality, Community-Acquired Infections epidemiology, Pseudomonas Infections mortality, Pseudomonas Infections epidemiology, Pseudomonas Infections microbiology, Bacteremia mortality, Bacteremia microbiology, Bacteremia epidemiology, Pseudomonas stutzeri
- Abstract
Background: The recognition of Pseudomonas stutzer i as a cause of infections in humans has been increasing. However, only case reports and small series of P. stutzeri bloodstream infections have been published. Epidemiological data on these infections are extremely scarce. Our objective was to describe the incidence, epidemiology, antimicrobial resistance rates, and outcomes of P. stutzeri bloodstream infections in a large population-based cohort in Australia., Methods: Retrospective, laboratory-based surveillance study conducted in Queensland, Australia (population ≈ 5 million) during 2000-2019. Clinical information was obtained from public hospital admissions and vital statistics databases., Results: In total, 228 episodes of P. stutzeri bloodstream infections were identified. Increased incidence was observed in the later years, especially in older men, and was higher during the rainy months of the year and in the warmest and more humid regions of the state. The majority of bloodstream infections were community-onset with 120 (52.6%) community-associated and 59 (25.9%) ambulatory healthcare-associated episodes. Only 49 cases (21.5%) were nosocomial. The most common foci of infection were skin and soft tissue, lower respiratory tract, and intra-abdominal. No isolate showed antimicrobial resistance. Thirty-one patients (13.6%) died. The mortality rate in patients with a respiratory infectious source was higher (21%)., Conclusions: P. stutzeri bloodstream infection was predominantly a community-onset condition including ambulatory healthcare related cases, with increasing incidence, especially in older males. No antimicrobial resistance was observed. Mortality was high in patients with respiratory infectious source. This new observational data have implications when considering the epidemiology of these infections and for patient management.
- Published
- 2024
- Full Text
- View/download PDF
26. A case of community-acquired Clostridioides difficile infection causing intussusception, severe pneumonia, and severe hypokalemia.
- Author
-
Iwashita Y, Takeuchi S, Hadano Y, Kawamura T, Tanaka Y, Sato R, Kodani N, Yamada N, and Saito R
- Subjects
- Humans, Male, Aged, 80 and over, Pneumonia microbiology, Pneumonia complications, Japan, Anti-Bacterial Agents therapeutic use, Diarrhea microbiology, Diarrhea etiology, Clostridioides difficile isolation & purification, Community-Acquired Infections microbiology, Community-Acquired Infections complications, Clostridium Infections complications, Clostridium Infections microbiology, Hypokalemia etiology, Intussusception microbiology, Intussusception etiology
- Abstract
Background: Clostridioides difficile infection is associated with antibiotic use and manifests as diarrhea; however, emerging cases of fulminant diarrhea caused by binary toxin-producing C. difficile unrelated to prior antibiotic exposure have been reported. Although fulminant colitis caused by C. difficile has been documented, instances of intussusception remain scarce. Here, we present a case of adult intussusception with severe hypokalemia and pneumonia resulting from a community-acquired C. difficile infection in Japan., Case Presentation: An 82-year-old male presented with dizziness, progressive weakness, and diarrhea. Initial vital signs indicated severe respiratory and circulatory distress, and laboratory findings revealed hypokalemia, pneumonia, and septic shock. Imaging confirmed intussusception of the ascending colon. Although colonoscopy suggested a potential tumor, no malignancy was found. The C. difficile rapid test result was positive, indicating community-acquired C. difficile infection. Treatment with vancomycin was initiated; however, intussusception relapsed. Surgical intervention was successful and led to clinical improvement. The patient's complex pathophysiology involved community-acquired C. difficile-induced severe diarrhea, hypokalemia, hypermetabolic alkalosis, and subsequent intussusception. Although adult intussusception is uncommon, this case was uniquely linked to binary toxin-producing C. difficile. The identified strain, SUH1, belonged to a novel sequence type (ST1105) and clade 3, suggesting a highly virulent clone. Resistome analysis aligned with phenotypic susceptibility to metronidazole and vancomycin, confirming their treatment efficacy., Conclusion: This case report highlights a binary toxin-producing C. difficile that caused intussusception. The consideration of community-acquired C. difficile in the differential diagnosis of severe enteritis is necessary, even in Japan., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
27. Genomic Profile of a Multidrug-Resistant Klebsiella pneumoniae Strain Isolated from a Urine Specimen.
- Author
-
Arauz-Cabrera J, Marquez-Salazar D, Delgadillo-Valles R, Caporal-Hernandez L, Hernandez-Acevedo GN, and Barrios-Villa E
- Subjects
- Humans, Community-Acquired Infections microbiology, Urine microbiology, Klebsiella pneumoniae genetics, Klebsiella pneumoniae drug effects, Klebsiella pneumoniae isolation & purification, Drug Resistance, Multiple, Bacterial genetics, Klebsiella Infections microbiology, Klebsiella Infections urine, Anti-Bacterial Agents pharmacology, Urinary Tract Infections microbiology, Genome, Bacterial, Microbial Sensitivity Tests, Phylogeny, Whole Genome Sequencing
- Abstract
Klebsiella pneumoniae is an opportunistic pathogen mostly found in health care-associated infections but can also be associated with community-acquired infections and is in critical need of new antimicrobial agents for strains resistant to carbapenems. The prevalence of carbapenemase-encoding genes varies among studies. Multidrug-resistant K. pneumoniae strains can harbor several antimicrobial-resistant determinants and mobile genetic elements (MGEs), along with virulence genetic determinants in community settings. We aim to determine the genetic profile of a multidrug-resistant K. pneumoniae strain isolated from a patient with community-acquired UTI. We isolated a K. pneumoniae strain UABC-Str0120, from a urine sample of community-acquired urinary tract infection. Antimicrobial susceptibility tests and Whole-genome sequencing (WGS) were performed. The phylogenetic relationship was inferred by SNPs calling and filtering. UABC-Str0120 showed resistance toward β-lactams, combinations with β-lactamase inhibitors, and carbapenems. WGS revealed the presence of genes conferring resistance to aminoglycosides, β-lactams, carbapenems, quinolones, sulfonamides, phosphonates, phenicols, and quaternary ammonium compounds, 77 subsystems of virulence genes were identified, and an uncommon sequence type ST5889 was also determined. The sequenced strain harbors several MGEs. The UABC-Str0120 recovered from a urine sample harbors several virulence and antimicrobial resistance determinants, which assembles an endangering combination for an immunocompromised or a seemly healthy host, given its presence in a community setting., (© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
28. The impact of the COVID-19 pandemic on Staphylococcus aureus infections in pediatric patients admitted with community acquired pneumonia.
- Author
-
Ai L, Fang L, Zhou C, Liu B, Yang Q, and Gong F
- Subjects
- Humans, Female, Male, Child, Child, Preschool, Retrospective Studies, Infant, Adolescent, Coinfection epidemiology, Coinfection microbiology, SARS-CoV-2 isolation & purification, SARS-CoV-2 drug effects, Methicillin-Resistant Staphylococcus aureus drug effects, Methicillin-Resistant Staphylococcus aureus isolation & purification, Pandemics, Hospitalization, Drug Resistance, Bacterial, COVID-19 epidemiology, COVID-19 microbiology, COVID-19 complications, Community-Acquired Infections epidemiology, Community-Acquired Infections microbiology, Community-Acquired Infections drug therapy, Staphylococcus aureus drug effects, Staphylococcus aureus isolation & purification, Staphylococcal Infections epidemiology, Staphylococcal Infections drug therapy, Staphylococcal Infections microbiology, Anti-Bacterial Agents therapeutic use, Anti-Bacterial Agents pharmacology
- Abstract
The COVID-19 pandemic has significantly transformed the infection spectrum of various pathogens. This study aimed to evaluate the impact of the COVID-19 pandemic on Staphylococcus aureus (S. aureus) infections among pediatric patients with community acquired pneumonia (CAP). We retrospectively reviewed pediatric CAP admissions before (from 2018 to 2019) and during (from 2020 to 2022) the COVID-19 pandemic. The epidemiology and antimicrobial resistance (AMR) profiles of S. aureus isolates were examined to assess the pandemic's effect. As a result, a total of 399 pediatric CAP patients with S. aureus infections were included. The positivity rate, gender, and age distribution of patients were similar across both periods. There was a marked reduction in respiratory co-infections with Haemophilus influenzae (H. influenzae) during the COVID-19 pandemic, compared to 2019. Additionally, there were significant changes in the resistance profiles of S. aureus isolates to various antibiotics. Resistance to oxacillin and tetracycline increased, whereas resistance to penicillin, gentamicin, and quinolones decreased. Notably, resistance to erythromycin significantly decreased in methicillin-resistant S. aureus (MRSA) strains. The number of S. aureus isolates, the proportion of viral co-infections, and the number of resistant strains typically peaked seasonally, primarily in the first or fourth quarters of 2018, 2019, and 2021. However, shifts in these patterns were noted in the first quarter of 2020 and the fourth quarter of 2022. These findings reveal that the COVID-19 pandemic has significantly altered the infection dynamics of S. aureus among pediatric CAP patients, as evidenced by changes in respiratory co-infections, AMR patterns, and seasonal trends., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
29. Mobile genetic element-driven genomic changes in a community-associated methicillin-resistant Staphylococcus aureus clone during its transmission in a regional community outbreak in Japan.
- Author
-
Katahira K, Gotoh Y, Kasama K, Yoshimura D, Itoh T, Shimauchi C, Tajiri A, and Hayashi T
- Subjects
- Japan epidemiology, Humans, Genome, Bacterial, Female, Plasmids genetics, Whole Genome Sequencing, Methicillin-Resistant Staphylococcus aureus genetics, Methicillin-Resistant Staphylococcus aureus isolation & purification, Methicillin-Resistant Staphylococcus aureus classification, Disease Outbreaks, Community-Acquired Infections microbiology, Community-Acquired Infections epidemiology, Community-Acquired Infections transmission, Interspersed Repetitive Sequences, Phylogeny, Staphylococcal Infections epidemiology, Staphylococcal Infections microbiology, Staphylococcal Infections transmission
- Abstract
Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infections are now a public health concern in both community and healthcare settings worldwide. We previously identified a suspected case of a maternity clinic-centred outbreak of CA-MRSA skin infection in a regional community in Japan by PFGE-based analysis. In this study, we performed genome sequence-based analyses of 151 CA-MRSA isolates, which included not only outbreak-related isolates that we previously defined based on identical or similar PFGE patterns but also other isolates obtained during the same period in the same region. Our analysis accurately defined 133 isolates as outbreak-related isolates, collectively called the TDC clone. They belonged to a CA-MRSA lineage in clonal complex (CC) 30, known as the South West Pacific (SWP) clone. A high-resolution phylogenetic analysis of these isolates combined with their epidemiological data revealed that the TDC clone was already present and circulating in the region before the outbreak was recognized, and only the isolates belonging to two sublineages (named SL4 and SL5) were directly involved in the outbreak. Long persistence in patients/carriers and frequent intrahousehold transmission of the TDC clone were also revealed by this analysis. Moreover, by systematic analyses of the genome changes that occurred in this CA-MRSA clone during transmission in the community, we revealed that most variations were associated with mobile genetic elements (MGEs). Variant PFGE types were generated by alterations of prophages and genomic islands or insertion sequence (IS)-mediated insertion of a plasmid or a sequence of unknown origin. Dynamic changes in plasmid content, which were linked to changes in antimicrobial resistance profiles in specific isolates, were generated by frequent gain and loss of plasmids, most of which were self-transmissible or mobilizable. The introduction of IS 256 by a plasmid (named pTDC02) into sublineage SL5 led to SL5-specific amplification of IS 256, and amplified IS 256 copies were involved in some of the structural changes of chromosomes and plasmids and generated variations in the repertoire of virulence-related genes in limited isolates. These data revealed how CA-MRSA genomes change during transmission in the community and how MGEs are involved in this process.
- Published
- 2024
- Full Text
- View/download PDF
30. To: Death by community-based methicillin-resistant Staphylococcus aureus: case report.
- Author
-
Scorza FA, Scorza CA, and Finsterer J
- Subjects
- Humans, Fatal Outcome, Male, Methicillin-Resistant Staphylococcus aureus, Staphylococcal Infections microbiology, Staphylococcal Infections drug therapy, Staphylococcal Infections mortality, Community-Acquired Infections microbiology, Community-Acquired Infections mortality, Community-Acquired Infections drug therapy
- Published
- 2024
- Full Text
- View/download PDF
31. Syndromic testing for respiratory pathogens but not National Early Warning Score can be used to identify viral cause in hospitalised adults with lower respiratory tract infections.
- Author
-
Bergbrant S, Sundell N, Andersson LM, Lindh M, Gustavsson L, and Westin J
- Subjects
- Humans, Male, Female, Middle Aged, Aged, Adult, Prospective Studies, Viruses isolation & purification, Viruses classification, Viruses genetics, Aged, 80 and over, Bacteria isolation & purification, Bacteria classification, Bacteria genetics, Anti-Bacterial Agents therapeutic use, Respiratory Tract Infections virology, Respiratory Tract Infections microbiology, Respiratory Tract Infections diagnosis, Virus Diseases diagnosis, Virus Diseases virology, Hospitalization, Multiplex Polymerase Chain Reaction, Community-Acquired Infections virology, Community-Acquired Infections microbiology, Community-Acquired Infections diagnosis, Bacterial Infections diagnosis, Bacterial Infections microbiology, Nasopharynx virology, Nasopharynx microbiology
- Abstract
Background: Community-acquired lower respiratory tract infection (LRTI) is a common reason for hospitalisation. Antibiotics are frequently used while diagnostic microbiological methods are underutilised in the acute setting., Objectives: We aimed to investigate the relative proportion of viral and bacterial infections in this patient group and explore methods for proper targeting of antimicrobial therapy., Methods: We collected nasopharyngeal samples prospectively from adults hospitalised with LRTIs during three consecutive winter seasons (2016-2019). Syndromic nasopharyngeal testing was performed using a multiplex PCR panel including 16 viruses and four bacteria. Medical records were reviewed for clinical data., Results: Out of 220 included patients, a viral pathogen was detected in 74 (34%), a bacterial pathogen in 63 (39%), both viral and bacterial pathogens in 49 (22%), while the aetiology remained unknown in 34 (15%) cases. The proportion of infections with an identified pathogen increased from 38% to 85% when syndromic testing was added to standard-of-care testing. Viral infections were associated with a low CRP level and absence of pulmonary infiltrates. A high National Early Warning Score did not predict bacterial infections., Conclusions: Syndromic testing by a multiplex PCR panel identified a viral infection or viral/bacterial coinfection in a majority of hospitalised adult patients with community-acquired LRTIs.
- Published
- 2024
- Full Text
- View/download PDF
32. Challenges in the treatment of pediatric Mycoplasma pneumoniae pneumonia.
- Author
-
Ding G, Zhang X, Vinturache A, van Rossum AMC, Yin Y, and Zhang Y
- Subjects
- Humans, Child, Community-Acquired Infections drug therapy, Community-Acquired Infections diagnosis, Community-Acquired Infections microbiology, Adolescent, Pneumonia, Mycoplasma drug therapy, Pneumonia, Mycoplasma diagnosis, Anti-Bacterial Agents therapeutic use, Macrolides therapeutic use, Mycoplasma pneumoniae isolation & purification, Drug Resistance, Bacterial
- Abstract
Mycoplasma pneumoniae (MP) is an important cause of community-acquired pneumonia in children and young adolescents. Despite macrolide antibiotics effectiveness as a first-line therapy, persistence of fever and/or clinical deterioration sometimes may complicate treatment and may even lead to severe systemic disease. To date, there is no consensus on alternative treatment options, optimal dosage, and duration for treating severe, progressive, and systemic MP pneumonia after macrolide treatment failure. Macrolide-resistant MP pneumonia and refractory MP pneumonia are the two major complex conditions that are clinically encountered. Currently, the vast majority of MP isolates are resistant to macrolides in East Asia, especially China, whereas in Europe and North America, whereas in Europe and North America prevalence is substantially lower than in Asia, varying across countries. The severity of pneumonia and extrapulmonary presentations may reflect the intensity of the host's immune reaction or the dissemination of bacterial infection. Children infected with macrolide-resistant MP strains who receive macrolide treatment experience persistent fever with extended antibiotic therapy and minimal decrease in MP-DNA load. Alternative second-line agents such as tetracyclines (doxycycline or minocycline) and fluoroquinolones (ciprofloxacin or levofloxacin) may lead to clinical improvement after macrolide treatment failure in children. Refractory MP pneumonia reflects a deterioration of clinical and radiological findings due to excessive immune response against the infection. Immunomodulators such as corticosteroids and intravenous immunoglobulin (IVIG) have shown promising results in treatment of refractory MP pneumonia, particularly when combined with appropriate antimicrobials. Corticosteroid-resistant hyperinflammatory MP pneumonia represents a persistent or recrudescent fever despite corticosteroid therapy with intravenous methylprednisolone at standard dosage., Conclusion: This report summarizes the clinical significance of macrolide-resistant and refractory MP pneumonia and discusses the efficacy and safety of alternative drugs, with a stepwise approach to the management of MP pneumonia recommended from the viewpoint of clinical practice., What Is Known: • Although MP pneumonia is usually a benign self-limited infection with response macrolides as first line therapy, severe life-threatening cases may develop if additional treatment strategies are not effectively implemented. • Macrolide-resistant and refractory MP pneumonia are two conditions that may complicate the clinical course of MP pneumonia, increasing the risk for exacerbation and even death., What Is New: • This report summarizes the clinical relevance of macrolide-resistant and refractory MP pneumonia and discusses the efficacy and safety of alternative drug therapies. • A practical stepwise approach to the management of MP pneumonia is developed based on a comprehensive analysis of existing evidence and expert opinion., (© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
33. Emergence of novel hypervirulent Acinetobacter baumannii strain and herpes simplex type 1 virus in a case of community-acquired pneumonia in China.
- Author
-
Wang Q, Liu H, Yao Y, Chen H, Yang Z, Xie H, Cui R, Liu H, Li C, Gong W, Yu Y, Hua X, and Li S
- Subjects
- Humans, China epidemiology, Animals, Virulence genetics, Anti-Bacterial Agents pharmacology, Virulence Factors genetics, Herpes Simplex virology, Pneumonia, Bacterial microbiology, Male, Genome, Bacterial, Moths microbiology, Moths virology, Community-Acquired Infections microbiology, Community-Acquired Infections epidemiology, Acinetobacter baumannii genetics, Acinetobacter baumannii pathogenicity, Acinetobacter baumannii drug effects, Acinetobacter baumannii isolation & purification, Acinetobacter Infections microbiology, Acinetobacter Infections epidemiology, Microbial Sensitivity Tests, Whole Genome Sequencing, Phylogeny, Herpesvirus 1, Human genetics, Herpesvirus 1, Human pathogenicity, Herpesvirus 1, Human isolation & purification
- Abstract
Background: A. baumannii is an important and common clinical pathogen, especially in the intensive care unit (ICU). This study aimed to characterize one hypervirulent A. baumannii strain in a patient with community-acquired pneumonia and herpes simplex type 1 virus infection., Methods: Minimum inhibitory concentrations (MICs) were determined using the Kirby-Bauer (K-B) and broth microdilution methods. Galleria mellonella infection model experiment was conducted. Whole-genome sequencing (WGS) was performed using the Illumina and Nanopore platforms. The resistance and virulence determinants were identified using the ABRicate program with ResFinder and the VFDB database. The capsular polysaccharide locus (K locus) and lipooligosaccharide outer core locus (OC locus) were identified using Kleborate with Kaptive. Phylogenetic analyses were conducted using the BacWGSTdb server., Results: A. baumannii XH2146 strain belongs to ST10
Pas and ST447Oxf . The strain was resistant to cefazolin, ciprofloxacin, and trimethoprim/sulfamethoxazole (TMP-SMX). Bautype and Kaptive analyses showed that XH2146 contains OCL2 and KL49. WGS analysis revealed that the strain harbored blaADC-76 , blaOXA-68 , ant(3'')-IIa, tet(B), and sul2. Notably, tet(B) and sul2, both were located within a 114,700-bp plasmid (designated pXH2146-1). Virulence assay revealed A. baumannii XH2146 possessed higher virulence than A. baumannii AB5075 at 12 h. Comparative genomic analysis showed that A. baumannii ST447 strains were mainly isolated from the USA and exhibited a relatively close genetic relationship. Importantly, 11 strains were observed to carry blaOXA-58 ; blaOXA-23 was identified in 11 isolates and three ST447 A. baumannii strains harbored blaNDM-1 ., Conclusions: Early detection of community-acquired hypervirulent Acinetobacter baumannii strains is recommended to prevent their extensive spread in hospitals., (Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
34. Unilateral lymphadenitis caused by community-associated methicillin-resistant Staphylococcus aureus ST834 strain.
- Author
-
Eda H, Arakawa Y, Yoshida T, Ogasawara F, Kojima K, Nakaminami H, and Yamagishi Y
- Subjects
- Humans, Female, Adolescent, Clindamycin therapeutic use, Microbial Sensitivity Tests, Linezolid therapeutic use, Methicillin-Resistant Staphylococcus aureus isolation & purification, Methicillin-Resistant Staphylococcus aureus genetics, Methicillin-Resistant Staphylococcus aureus drug effects, Staphylococcal Infections microbiology, Staphylococcal Infections drug therapy, Staphylococcal Infections diagnosis, Lymphadenitis microbiology, Lymphadenitis drug therapy, Community-Acquired Infections microbiology, Community-Acquired Infections drug therapy, Anti-Bacterial Agents therapeutic use, Anti-Bacterial Agents pharmacology
- Abstract
Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) is a global concern, primarily as a cause of skin and soft tissue infections, particularly in young people. Here, we describe a case of unilateral multiple lymphadenitis caused by the CA-MRSA sequence type (ST) 834 strain. A previously healthy 15-year-old girl was referred to our hospital with fever and swollen lymph nodes in the right axillary, cubital, and groin regions. Imaging examinations revealed enlargement of the lymph nodes in these areas but no swelling in any other lymph nodes. The patient had self-destructive lymph nodes in her groin. MRSA was detected in all swollen lymph node samples. Antimicrobial susceptibility tests showed that MRSA was susceptible to clindamycin and levofloxacin, leading to the suspicion of CA-MRSA. Genetic analysis revealed that all strains were ST834 and carried the staphylococcal cassette chromosome mec IV and the toxic shock syndrome toxin-1 gene but not the Panton-Valentine leukocidin gene. The patient was treated with linezolid followed by oral clindamycin. This was a rare case of unilateral multiple lymphadenitis caused by ST834 CA-MRSA. Although ST834 strains are rarely reported, lymphadenitis has been frequently reported and is considered more likely to cause lymphadenitis than other CA-MRSA strains., Competing Interests: Declaration of competing interest None., (Copyright © 2023 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
35. Advances in the pathogenesis and treatment of pneumococcal meningitis.
- Author
-
Xu Y, Wang J, Qin X, and Liu J
- Subjects
- Humans, Blood-Brain Barrier microbiology, Pneumococcal Vaccines immunology, Animals, Community-Acquired Infections microbiology, Anti-Bacterial Agents therapeutic use, Meningitis, Pneumococcal microbiology, Meningitis, Pneumococcal drug therapy, Meningitis, Pneumococcal therapy, Streptococcus pneumoniae pathogenicity
- Abstract
Streptococcus pneumoniae is a common pathogen associated with community-acquired bacterial meningitis, characterized by high morbidity and mortality rates. While vaccination reduces the incidence of meningitis, many survivors experience severe brain damage and corresponding sequelae. The pathogenesis of pneumococcal meningitis has not been fully elucidated. Currently, meningitis requires bacterial disruption of the blood - brain barrier, a process that involves the interaction of bacterial surface components with host cells and various inflammatory responses. This review delineates the global prevalence, pathogenesis, and treatment strategies of pneumococcal meningitis. The objective is to enhance the thorough comprehension of the clinical manifestations and biological mechanisms of the disease, thereby enabling more efficient prevention, diagnosis, and therapeutic interventions.
- Published
- 2024
- Full Text
- View/download PDF
36. Complicated pneumonia caused by group A Streptococcus in children - 2022/2023 infectious season outbreak and update on clinical characteristics.
- Author
-
Grochowska M, Strzelak A, and Krenke K
- Subjects
- Humans, Female, Male, Retrospective Studies, Child, Child, Preschool, Poland epidemiology, Infant, Adolescent, COVID-19 epidemiology, COVID-19 complications, Incidence, Pneumonia, Bacterial epidemiology, Pneumonia, Bacterial microbiology, Pneumonia, Bacterial diagnosis, Hospitalization statistics & numerical data, Streptococcal Infections epidemiology, Streptococcal Infections microbiology, Streptococcal Infections complications, Streptococcus pyogenes isolation & purification, Community-Acquired Infections epidemiology, Community-Acquired Infections microbiology, Disease Outbreaks
- Abstract
Background: An increased incidence of group A Streptococcus (GAS) infections has been observed in pediatric population post-COVID-19 pandemic. While the majority of reports refer to scarlet fever or invasive GAS disease, detailed data on pulmonary manifestations such as complicated community-acquired pneumonia (CAP) are scarce. The aim of this study was to assess the contribution of GAS to complicated CAP in children during the 2022/2023 infectious season., Methods: We retrospectively analyzed the etiology and clinical presentation of complicated CAP patients hospitalized in our tertiary care center in Warsaw, Poland, between August 2022 and May 2023., Results: Among 91 patients with complicated CAP, GAS was the dominant cause constituting 24.2% (22/91; 95% CI 15.8-34.3%) of the study group. 68.2% of GAS pneumonia patients presented symptoms of scarlet fever, and 27.3% had preceding or concurrent viral infection. GAS complicated CAP was associated with longer hospitalization, higher incidence of chest tube insertion, but shorter duration of chest tube drainage than complicated CAP of other etiology. Children with GAS complicated CAP had higher procalcitonin concentration (28.1 vs. 1.5 ng/dL; p<0.0001) and a lower platelets level (254.5 vs. 422 × 10
3 /μL; p = 0.0031) than those with non-GAS infection., Conclusions: GAS is currently the predominant pathogen of complicated CAP in children. Clinicians should be aware of the current epidemiological situation and a more severe course of GAS pneumonia in this age group, and should monitor patients presenting with symptoms of scarlet fever and preceding viral infection closely., Competing Interests: Declaration of competing interest The authors declare no conflict of interest., (Copyright © 2024 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
37. The etiological diagnostic value of metagenomic next-generation sequencing in suspected community-acquired pneumonia.
- Author
-
Liu M, Zhang H, Li L, Mao J, Li R, Yin J, and Wu X
- Subjects
- Humans, Male, Female, Middle Aged, Aged, Adult, Pneumonia diagnosis, Pneumonia microbiology, Pneumonia drug therapy, Sputum microbiology, Aged, 80 and over, Bacteria isolation & purification, Bacteria genetics, Bacteria classification, Young Adult, Community-Acquired Infections microbiology, Community-Acquired Infections diagnosis, Community-Acquired Infections drug therapy, High-Throughput Nucleotide Sequencing methods, Metagenomics methods, Bronchoalveolar Lavage Fluid microbiology
- Abstract
Background: The emergence of metagenomic next-generation sequencing (mNGS) may provide a promising tool for early and comprehensive identification of the causative pathogen in community-acquired pneumonia (CAP). In this study, we aim to further evaluate the etiological diagnostic value of mNGS in suspected CAP., Methods: A total of 555 bronchoalveolar lavage fluid (BALF) samples were collected for pathogen detection by mNGS from 541 patients with suspected CAP. The clinical value was assessed based on infection diagnosis and treatment guidance. The diagnostic performance for pathogen identification by mNGS and sputum culture and for tuberculosis (TB) by mNGS and X-pert MTB/RIF were compared. To evaluate the potential for treatment guidance, we analyzed the treatment regimen of patients with suspected CAP, including imaging changes of lung after empirical antibacterial therapy, intensified regimen, antifungal treatment, and a 1-year follow up for patients with unconfirmed diagnosis and non-improvement imaging after anti-infective treatment and patients with high suspicion of TB or NTM infection who were transferred to the Wuhan Pulmonary Hospital for further diagnosis and even anti-mycobacterium therapy., Results: Of the 516 BALF samples that were analyzed by both mNGS and sputum culture, the positivity rate of mNGS was significantly higher than that of sputum culture (79.1% vs. 11.4%, P = 0.001). A total of 48 samples from patients with confirmed TB were analyzed by both mNGS and X-pert MTB/RIF, and the sensitivity of mNGS for the diagnosis of active TB was significantly lower than that of X-pert MTB/RIF (64.6% vs. 85.4%, P = 0.031). Of the 106 pathogen-negative cases, 48 were ultimately considered non-infectious diseases, with a negative predictive value of 45.3%. Of the 381 pathogen-positive cases, 311 were eventually diagnosed as CAP, with a positive predictive value of 81.6%. A total of 487 patients were included in the evaluation of the therapeutic effect, and 67.1% improved with initial empirical antibiotic treatment. Of the 163 patients in which bacteria were detected, 77.9% improved with antibacterial therapy; of the 85 patients in which fungi were detected, 12.9% achieved remission after antifungal therapy., Conclusions: Overall, mNGS had unique advantages in the detection of suspected CAP pathogens. However, mNGS was not superior to X-pert MTB/RIF for the diagnosis of TB. In addition, mNGS was not necessary as a routine test for all patients admitted with suspected CAP. Furthermore, when fungi are detected by mNGS, antifungal therapy should be cautious., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
38. Association between time to surgery and hospital mortality in patients with community-acquired limb necrotizing fasciitis: an 11-year multicenter retrospective cohort analysis.
- Author
-
Lau CH, Ling L, Zhang JZ, Ng PY, Chan CY, Yeung AWT, Fong KM, Chan JKH, Au GKF, Liong T, Dharmangadan M, Chow FL, Lam KN, Chan KM, Ling S, and Lee A
- Subjects
- Humans, Male, Female, Retrospective Studies, Middle Aged, Aged, Hong Kong epidemiology, Community-Acquired Infections mortality, Community-Acquired Infections surgery, Community-Acquired Infections microbiology, Time-to-Treatment, Extremities surgery, Extremities pathology, Adult, Intensive Care Units statistics & numerical data, Aged, 80 and over, Fasciitis, Necrotizing mortality, Fasciitis, Necrotizing surgery, Fasciitis, Necrotizing microbiology, Hospital Mortality, Anti-Bacterial Agents therapeutic use
- Abstract
Background: Necrotizing fasciitis (NF) is a rare but potentially life-threatening soft tissue infection. The objective of this study was to assess the association between timely surgery within 6 h and hospital mortality in patients with limb NF, and to describe the trends in patients with NF, time to surgery and standardized mortality ratio (SMR) over 11 years., Methods: This was a multicenter, retrospective cohort study of all intensive care unit patients who had emergency surgery within 24 h of hospitalization for limb NF between April 1, 2008 and March 31, 2019 in Hong Kong. Timely surgery was defined as the first surgical treatment within 6 h of initial hospitalization. Appropriate antibiotics were achieved if the patient was given antibiotic(s) for all documented pathogens prior to or on day of culture results. The primary outcome was hospital mortality., Results: There were 495 patients (median age 62 years, 349 (70.5%) males) with limb NF treated by surgery within 24 h of hospitalization over the 11 years. Appropriate antibiotic(s) were used in 392 (79.2%) patients. There were 181 (36.5%) deaths. Timely surgery was not associated with hospital mortality (Relative Risk 0.89, 95% CI: 0.73 to 1.07) but admission year, advanced age, higher severity of illness, comorbidities, renal replacement therapy, vasopressor use, and type of surgery were significant predictors in the multivariable model. There was an upward trend in NF diagnosis (1.9 cases/year, 95% CI: 0.7 to 3.1; P < 0.01; R
2 = 0.60) but there was no downward trend in median time to surgery (-0.2 h/year, 95% CI: -0.4 to 0.1; P = 0.16) or SMR (-0.02/year, 95% CI: -0.06 to 0.01; P = 0.22; R2 = 0.16)., Conclusions: Among patients operated within 24 h, very early surgery within 6-12 h was not associated with survival. Increasing limb NF cases were reported each year but mortality remained high despite a high rate of appropriate antibiotic use and timely surgical intervention., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF
39. First Report of Klebsiella pneumoniae subsp. ozaenae Meningitis in Japan.
- Author
-
Hosono Honda N, Harada S, Suzuki M, Akaiwa Y, Miyashita K, Miyamoto T, and Haruki K
- Subjects
- Aged, Female, Humans, Community-Acquired Infections microbiology, Community-Acquired Infections diagnosis, Japan epidemiology, Klebsiella Infections diagnosis, Klebsiella Infections microbiology, Klebsiella Infections complications, Klebsiella pneumoniae isolation & purification, Meningitis, Bacterial diagnosis, Meningitis, Bacterial microbiology
- Abstract
Although the frequency of community-acquired infections caused by Klebsiella pneumoniae subsp. ozaenae (K. ozaenae) is low, they are often detected in sputum specimens. In addition, lung abscesses, necrotizing pneumonia, and urinary tract infections caused by K. ozaenae have also been reported. We herein report the first detection of K. ozaenae as an etiological agent of bacterial meningitis in Japan. Cases of K. ozaenae meningitis complicated by diabetes mellitus and sinusitis have been reported elsewhere. When Klebsiella pneumoniae is detected in such cases, it is important to use other detection methods in addition to mass spectrometry for correct identification.
- Published
- 2024
- Full Text
- View/download PDF
40. Community-Acquired Staphylococcus aureus Bacteremia Among People Who Inject Drugs: A National Cohort Study in England, 2017-2020.
- Author
-
McGuire E, Collin SM, Brown CS, and Saito M
- Subjects
- Humans, Male, Female, England epidemiology, Adult, Middle Aged, Cohort Studies, Patient Readmission statistics & numerical data, Aged, Young Adult, Risk Factors, Staphylococcal Infections epidemiology, Staphylococcal Infections mortality, Bacteremia epidemiology, Bacteremia mortality, Substance Abuse, Intravenous complications, Substance Abuse, Intravenous epidemiology, Community-Acquired Infections epidemiology, Community-Acquired Infections microbiology, Community-Acquired Infections mortality, Staphylococcus aureus
- Abstract
Background: People who inject drugs (PWID) are at increased risk of community-acquired Staphylococcus aureus bacteremia (CA-SAB), but little is known about clinical outcomes of CA-SAB in PWID compared with the wider population of patients with CA-SAB., Methods: Three national datasets were linked to provide clinical and mortality data on patients hospitalized with CA-SAB in England between 1 January 2017 and 31 December 2020. PWID were identified using the International Classification of Diseases, Tenth Revision code for "mental health and behavioral disorder due to opioid use" (F11). Multivariable logistic regression was used to estimate adjusted odds ratios (aORs) for associations of PWID with 30-day all-cause mortality and 90-day hospital readmission., Results: In 10 045 cases of CA-SAB, 1612 (16.0%) were PWID. Overall, 796 (7.9%) patients died within 30 days of CA-SAB admission and 1189 (11.8%) patients were readmitted to hospital within 90 days of CA-SAB. In those without infective endocarditis, there was strong evidence of lower odds of mortality among PWID compared with non-PWID (aOR, 0.47 [95% confidence interval {CI}: .33-.68]; P < .001), whereas there was no association in CA-SAB case fatality with endocarditis (aOR, 1.40 [95% CI: .87-2.25]; P = .163). PWID were less likely to be readmitted within 90 days of CA-SAB (aOR, 0.79 [95% CI: .65-.95]; P = .011)., Conclusions: In this large cohort study of patients with CA-SAB in England, PWID had lower odds of death in the absence of endocarditis and lower odds of readmission within 90 days compared to non-PWID patients. This study highlights the overrepresentation of PWID among patients with CA-SAB nationally., Competing Interests: Potential conflicts of interest. All authors declare that they have no commercial or other association that might pose a conflict of interest. S. M. C. reports stock options in AstraZeneca. C. S. B reports ad hoc one-off market research advisory conducted anonymously via market research companies with no direct communication nor any knowledge of any pharmaceutical companies or products (one has related to S. aureus within the past 36 months, on avpre-surgical nasal S. aureus decolonization protocol). All other authors report no potential conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed., (© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.)
- Published
- 2024
- Full Text
- View/download PDF
41. Clinical Testing Guidance for Coccidioidomycosis, Histoplasmosis, and Blastomycosis in Patients With Community-Acquired Pneumonia for Primary and Urgent Care Providers.
- Author
-
Smith DJ, Free RJ, Thompson GR 3rd, Baddley JW, Pappas PG, Benedict K, Gold JAW, Tushla LA, Chiller T, Jackson BR, and Toda M
- Subjects
- Humans, Ambulatory Care, Primary Health Care, Practice Guidelines as Topic, Blastomycosis diagnosis, Blastomycosis drug therapy, Histoplasmosis diagnosis, Histoplasmosis drug therapy, Coccidioidomycosis diagnosis, Coccidioidomycosis drug therapy, Community-Acquired Infections diagnosis, Community-Acquired Infections microbiology, Pneumonia diagnosis, Pneumonia microbiology
- Abstract
Coccidioidomycosis, histoplasmosis, and blastomycosis are underrecognized and frequently misdiagnosed fungal infections that can clinically resemble bacterial and viral community-acquired pneumonia. This guidance is intended to help outpatient clinicians test for these fungal diseases in patients with community-acquired pneumonia to reduce misdiagnoses, unnecessary antibacterial use, and poor outcomes., Competing Interests: Potential conflicts of interest. J. W. B. reports payments from Up-to-Date for serving as an author or editor for sections on histoplasmosis. P. G. P. reports institutional support from Cidara, Amplyx, Pfizer, F2G, Mayne Pharmaceuticals, Merck & Co., Inc, and Astellas and personal payments for participation on a Data Safety Monitoring Board or Advisory Board from F2G, Matinas, and Cidara. G. R. T. III reports support from Cidara, Amplyx, Pfizer, F2G, Mayne Pharmaceuticals, and Merck & Co., Inc. L. A. T. reports grants from BMS and Novartis for a skin cancer health equity project in farmworker communities. All other authors report no potential conflicts. All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. This activity was reviewed by the Centers for Disease Control and Prevention and was conducted consistent with applicable federal law and Centers for Disease Control and Prevention policy; see for example, 45 C.F.R. part 46.102(l)(2), 21 C.F.R. part 56; 42 U.S.C. §241(d); 5 U.S.C. §552a; 44 U.S.C. §3501 et seq., (Published by Oxford University Press on behalf of Infectious Diseases Society of America 2023.)
- Published
- 2024
- Full Text
- View/download PDF
42. Exploring the microbiota difference of bronchoalveolar lavage fluid between community-acquired pneumonia with or without COPD based on metagenomic sequencing: a retrospective study.
- Author
-
Wang B, Tan M, Li W, Xu Q, Jin L, Xie S, and Wang C
- Subjects
- Humans, Male, Retrospective Studies, Aged, Female, Middle Aged, High-Throughput Nucleotide Sequencing, Pneumonia microbiology, Aged, 80 and over, Pulmonary Disease, Chronic Obstructive microbiology, Bronchoalveolar Lavage Fluid microbiology, Community-Acquired Infections microbiology, Microbiota genetics, Metagenomics methods
- Abstract
Background: Community-acquired pneumonia (CAP) patients with chronic obstructive pulmonary disease (COPD) have higher disease severity and mortality compared to those without COPD. However, deep investigation into microbiome distribution of lower respiratory tract of CAP with or without COPD was unknown., Methods: So we used metagenomic next generation sequencing (mNGS) to explore the microbiome differences between the two groups., Results: Thirty-six CAP without COPD and 11 CAP with COPD cases were retrieved. Bronchoalveolar lavage fluid (BALF) was collected and analyzed using untargeted mNGS and bioinformatic analysis. mNGS revealed that CAP with COPD group was abundant with Streptococcus, Prevotella, Bordetella at genus level and Cutibacterium acnes, Rothia mucilaginosa, Bordetella genomosp. 6 at species level. While CAP without COPD group was abundant with Ralstonia, Prevotella, Streptococcus at genus level and Ralstonia pickettii, Rothia mucilaginosa, Prevotella melaninogenica at species level. Meanwhile, both alpha and beta microbiome diversity was similar between groups. Linear discriminant analysis found that pa-raburkholderia, corynebacterium tuberculostearicum and staphylococcus hominis were more enriched in CAP without COPD group while the abundance of streptococcus intermedius, streptococcus constellatus, streptococcus milleri, fusarium was higher in CAP with COPD group., Conclusions: These findings revealed that concomitant COPD have an mild impact on lower airway microbiome of CAP patients., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
43. [Pay attention to new evolution trends in the etiology of community-acquired pneumonia in adults].
- Author
-
He LX
- Subjects
- Humans, Adult, Mycoplasma pneumoniae, Pneumonia microbiology, Pneumonia etiology, Drug Resistance, Multiple, Bacterial, Coinfection, China epidemiology, Anti-Bacterial Agents therapeutic use, Community-Acquired Infections microbiology, Community-Acquired Infections epidemiology, Community-Acquired Infections etiology, Streptococcus pneumoniae
- Abstract
Over the past two to three decades, the emergence and re-emergence of new infectious diseases, advances in molecular detection techniques of pathogens, antibiotic resistance, changes in population lifestyle and immune status (including vaccination), and other factors have led to new evolutions in the etiology of community-acquired pneumonia (CAP). (1) Although Streptococcus pneumoniae remains a common pathogen of CAP, it is no longer the leading cause in China and the United States. According to the results of 2 multicenter studies in China in the early 21st century, Streptococcus pneumoniae accounted for 10.3% and 12.0% of adult CAP pathogens, respectively, ranking second. A study on key pathogens of adult CAP in nine cities in mainland China from 2014 to 2019 using real-time quantitative PCR and conventional culture on respiratory and blood specimens showed an overall prevalence of Streptococcus pneumoniae of 7.43%, ranking sixth. However, its ranking varied from third to seventh among the nine cities. (2) Challenges and concerns about viruses have increased. National surveillance of acute respiratory tract infections and epidemiology in China from 2009 to 2019 indicated that the positivity rates for viral infections in adult pneumonia was 20.5%. These rates were similar to the results of the CDC's CAP pathogen study in the United States, although the rankings were different (viruses ranked second in China and first in the United States). Over the past 20 years, the emergence of new viral respiratory infections caused by mutant strains or zoonotic strains has significantly increased the challenges and threats posed by viral respiratory infections. (3) The role of Mycoplasma pneumoniae ( M pneumoniae ) in adult CAP and the need for routine empirical antibiotic coverage are controversial. In addition to the influence of epidemic cycles, the prevalence of M pneumoniae is influenced by factors such as age, season, study design, and detection methods, and geographical distribution is also an important influencing factor. Although M. pneumoniae ranks first among CAP pathogens in mainland China (11.05%), there are significant regional differences. In Beijing, Xi'an, and Changchun M. pneumoniae ranks first, while in Harbin, Nanjing, and Fuzhou it ranks second to sixth. In Wuhan, Shenzhen, and Chengdu M. pneumoniae ranks after the tenth position. Available evidence supports the notion that routine coverage of M. pneumoniae is not necessary for empirical treatment of CAP, except in severe cases. In regions with a high prevalence of M. pneumoniae , the decision to cover atypical pathogens in patients with mild to moderate CAP should be based on local data and individualized. (4) CAP caused by multidrug-resistant bacteria, especially multidrug-resistant Gram-negative bacilli (GNB), has become a concern. According to a systematic review of Chinese literature, Klebsiella pneumoniae accounted for 8.12% of adult CAP patients, ranking fifth, and Pseudomonas aeruginosa accounted for 4.7% (ninth). The China Antimicrobial Resistance Surveillance System (CARSS) reported an average resistance rate of 27.7% for Klebsiella pneumoniae to third-generation cephalosporins and a resistance rate of 10.0% to carbapenems in 2021. The average resistance rate of Pseudomonas aeruginosa to carbapenems was 16.6%. Early empirical treatment should consider predicting the resistance profile using a "locally validated risk factor" scoring system. (5) Co-infections are common but under-reported. The development of non-culture detection techniques over the past 40 years has significantly increased the detection rate of respiratory pathogens, especially viruses, leading to an increasing number of reports of bacterial-viral co-infections in CAP. It has been reported that co-infections account for 39% of severe CAP cases on ventilators in the ICU. Currently, there is inconsistency and confusion regarding the definition and concept of co-infection, the choice of detection techniques, and the differentiation between co-detection and co-infection. Many reports of co-infections in COVID-19 lacked pathogenic evidence, and some even listed "effective antibiotic treatment" as one of the diagnostic criteria for viral-bacterial co-infections, suggesting to some extent an overuse of antibiotics in COVID-19. Due to the diverse etiological spectrum of CAP between regions in the recent years, it is challenging to develop unified guidelines for the management of CAP in large countries. This article provides recommendations for the development of local guidelines for the diagnosis and treatment of CAP.
- Published
- 2024
- Full Text
- View/download PDF
44. Microbiological diagnosis of pleural infections: a comparative evaluation of a novel syndromic real-time PCR panel.
- Author
-
Kommedal Ø, Eagan TM, Fløtten Ø, Leegaard TM, Siljan W, Fardal H, Bø B, Grøvan F, Larssen KW, Kildahl-Andersen A, Hjetland R, Tilseth R, Hareide SKØ, Tellevik M, and Dyrhovden R
- Subjects
- Humans, Bacterial Infections diagnosis, Bacterial Infections microbiology, Middle Aged, Male, DNA, Bacterial genetics, Female, Community-Acquired Infections diagnosis, Community-Acquired Infections microbiology, Aged, High-Throughput Nucleotide Sequencing methods, RNA, Ribosomal, 16S genetics, Adult, Pleural Diseases diagnosis, Pleural Diseases microbiology, Sensitivity and Specificity, Aged, 80 and over, Real-Time Polymerase Chain Reaction methods, Bacteria genetics, Bacteria isolation & purification, Bacteria classification
- Abstract
Current microbial diagnostics for pleural infections are insufficient. Studies using 16S targeted next-generation sequencing report that only 10%-16% of bacteria present are cultured and that 50%-78% of pleural fluids containing relevant microbial DNA remain culture negative. As a rapid diagnostic alternative suitable for clinical laboratories, we wanted to explore a PCR-based approach. Based on the identification of key pathogens, we developed a syndromic PCR panel for community-acquired pleural infections (CAPIs). This was a pragmatic PCR panel, meaning that it was not designed for detecting all possibly involved bacterial species but for confirming the diagnosis of CAPI, and for detecting bacteria that might influence choice of antimicrobial treatment. We evaluated the PCR panel on 109 confirmed CAPIs previously characterized using culture and 16S targeted next-generation sequencing. The PCR secured the diagnosis of CAPI in 107/109 (98.2%) and detected all present pathogens in 69/109 (63.3%). Culture secured the diagnosis in 54/109 (49.5%) and detected all pathogens in 31/109 (28.4%). Corresponding results for 16S targeted next-generation sequencing were 109/109 (100%) and 98/109 (89.9%). For bacterial species included in the PCR panel, PCR had a sensitivity of 99.5% (184/185), culture of 21.6% (40/185), and 16S targeted next-generation sequencing of 92.4% (171/185). None of the bacterial species present not covered by the PCR panel were judged to impact antimicrobial therapy. A syndromic PCR panel represents a rapid and sensitive alternative to current diagnostic approaches for the microbiological diagnosis of CAPI.IMPORTANCEPleural empyema is a severe infection with high mortality and increasing incidence. Long hospital admissions and long courses of antimicrobial treatment drive healthcare and ecological costs. Current methods for microbiological diagnostics of pleural infections are inadequate. Recent studies using 16S targeted next-generation sequencing as a reference standard find culture to recover only 10%-16% of bacteria present and that 50%-78% of samples containing relevant bacterial DNA remain culture negative. To confirm the diagnosis of pleural infection and define optimal antimicrobial therapy while limiting unnecessary use of broad-spectrum antibiotics, there is a need for rapid and sensitive diagnostic approaches. PCR is a rapid method well suited for clinical laboratories. In this paper we show that a novel syndromic PCR panel can secure the diagnosis of pleural infection and detect all bacteria relevant for choice of antimicrobial treatment with a high sensitivity., Competing Interests: Ø.K. is a co-founder and shareholder in Pathogenomix Inc. T.M.E. has received grants from GlaxoSmithKline and payment/honoraria from Boehringer Ingelheim, AstraZeneca, and SOS International. T.M.E. also reports participation on a data safety monitoring board (DSMB) for a nutrition study, Helse Sør-Øst, Lillehammer. T.M.E. is leader of the committee for the education of specialists in pulmonary medicine, Norway. T.M.L. is a member of the Professional Advisory Board, GenMark Diagnostics (ePlex), and has received honoraria for time spent. T.M.L. is the president of European Union of Medical Specialists (UEMS) Section of Medical Microbiology and member of Professional Affairs Subcommittee, European Society of Clinical Microbiology and Infectious Diseases (ESCMID). All other authors declare no competing interests.
- Published
- 2024
- Full Text
- View/download PDF
45. Case Report: Severe Community-Acquired Pneumonia in Réunion Island due to Acinetobacter baumannii.
- Author
-
Rotini G, de Mangou A, Combe A, Jabot J, Puech B, Dangers L, Nativel M, Allou N, Miltgen G, and Vidal C
- Subjects
- Humans, Male, Middle Aged, Female, Reunion epidemiology, Aged, Retrospective Studies, Adult, Pneumonia, Bacterial microbiology, Pneumonia, Bacterial epidemiology, Pneumonia, Bacterial complications, Pneumonia, Bacterial drug therapy, Shock, Septic microbiology, Shock, Septic epidemiology, Respiratory Distress Syndrome epidemiology, Respiratory Distress Syndrome microbiology, Acinetobacter baumannii, Community-Acquired Infections microbiology, Community-Acquired Infections epidemiology, Community-Acquired Infections drug therapy, Acinetobacter Infections epidemiology, Acinetobacter Infections drug therapy, Acinetobacter Infections microbiology, Anti-Bacterial Agents therapeutic use
- Abstract
Acinetobacter baumannii (Ab) is a well-known nosocomial pathogen that has emerged as a cause of community-acquired pneumonia (CAP) in tropical regions. Few global epidemiological studies of CAP-Ab have been published to date, and no data are available on this disease in France. We conducted a retrospective chart review of severe cases of CAP-Ab admitted to intensive care units in Réunion University Hospital between October 2014 and October 2022. Eight severe CAP-Ab cases were reviewed. Median patient age was 56.5 years. Sex ratio (male-to-female) was 3:1. Six cases (75.0%) occurred during the rainy season. Chronic alcohol use and smoking were found in 75.0% and 87.5% of cases, respectively. All patients presented in septic shock and with severe acute respiratory distress syndrome. Seven patients (87.5%) presented in cardiogenic shock, and renal replacement therapy was required for six patients (75.0%). Five cases (62.5%) presented with bacteremic pneumonia. The mortality rate was 62.5%. The median time from hospital admission to death was 3 days. All patients received inappropriate initial antibiotic therapy. Acinetobacter baumannii isolates were all susceptible to ceftazidime, cefepime, piperacillin-tazobactam, ciprofloxacin, gentamicin, and imipenem. Six isolates (75%) were also susceptible to ticarcillin, piperacillin, and cotrimoxazole. Severe CAP-Ab has a fulminant course and high mortality. A typical case is a middle-aged man with smoking and chronic alcohol use living in a tropical region and developing severe CAP during the rainy season. This clinical presentation should prompt administration of antibiotic therapy targeting Ab.
- Published
- 2024
- Full Text
- View/download PDF
46. Genomic characterization of Staphylococcus aureus isolated from patients admitted to intensive care units of a tertiary care hospital: epidemiological risk of nasal carriage of virulent clone during admission.
- Author
-
Inagawa T, Hisatsune J, Kutsuno S, Iwao Y, Koba Y, Kashiyama S, Ota K, Shime N, and Sugai M
- Subjects
- Humans, Cross Infection microbiology, Cross Infection epidemiology, Whole Genome Sequencing, Male, Molecular Epidemiology, Nose microbiology, Female, Virulence genetics, Community-Acquired Infections microbiology, Community-Acquired Infections epidemiology, Aged, Middle Aged, Genome, Bacterial, Genotype, Staphylococcal Infections microbiology, Staphylococcal Infections epidemiology, Intensive Care Units, Tertiary Care Centers, Virulence Factors genetics, Methicillin-Resistant Staphylococcus aureus genetics, Methicillin-Resistant Staphylococcus aureus isolation & purification, Methicillin-Resistant Staphylococcus aureus pathogenicity, Carrier State microbiology, Carrier State epidemiology, Staphylococcus aureus genetics, Staphylococcus aureus isolation & purification, Staphylococcus aureus pathogenicity
- Abstract
We conducted a molecular epidemiological study of Staphylococcus aureus using whole-genome sequence data and clinical data of isolates from nasal swabs of patients admitted to the intensive care unit (ICU) of Hiroshima University hospital. The relationship between isolate genotypes and virulence factors, particularly for isolates that caused infectious diseases during ICU admission was compared with those that did not. The nasal carriage rates of methicillin-resistant S. aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) in patients admitted to the ICU were 7.0% and 20.1%, respectively. The carriage rate of community-acquired (CA)-MRSA was 2.3%, accounting for 32.8% of all MRSA isolates. Whole-genome sequencing analysis of the MRSA isolates indicated that most, including CA-MRSA and healthcare-associated (HA)-MRSA, belonged to clonal complex (CC) 8 [sequence type (ST) 8] and SCC mec type IV. Furthermore, results for three disease foci (pneumonia, skin and soft tissue infection, and deep abscess) and the assessment of virulence factor genes associated with disease conditions [bacteremia, acute respiratory distress syndrome (ARDS), disseminated intravascular coagulopathy (DIC), and septic shock] suggested that nasal colonization of S. aureus clones could represent a risk for patients within the ICU. Particularly, MRSA/J and MSSA/J may be more likely to cause deep abscess infection; ST764 may cause ventilation-associated pneumonia, hospital-acquired pneumonia and subsequent bacteremia, and ARDS, and tst-1 -positive isolates may cause DIC onset.IMPORTANCENasal colonization of MRSA in patients admitted to the intensive care unit (ICU) may predict the development of MRSA infections. However, no bacteriological data are available to perform risk assessments for Staphylococcus aureus infection onset. In this single-center 2-year genomic surveillance study, we analyzed all S. aureus isolates from nasal swabs of patients admitted to the ICU and those from the blood or lesions of in-patients who developed infectious diseases in the ICU. Furthermore, we identified the virulent clones responsible for causing infectious diseases in the ICU. Herein, we report several virulent clones present in the nares that are predictive of invasive infections. This information may facilitate the design of preemptive strategies to identify and eradicate virulent MRSA strains, reducing nosocomial infections within the ICU., Competing Interests: The authors declare no conflict of interest.
- Published
- 2024
- Full Text
- View/download PDF
47. Molecular characterization and descriptive analysis of carbapenemase-producing Gram-negative rod infections in Bogota, Colombia.
- Author
-
Ibáñez-Prada ED, Bustos IG, Gamboa-Silva E, Josa DF, Mendez L, Fuentes YV, Serrano-Mayorga CC, Baron O, Ruiz-Cuartas A, Silva E, Judd LM, Harshegyi T, Africano HF, Urrego-Reyes J, Beltran CC, Medina S, Leal R, Stewardson AJ, Wyres KL, Hawkey J, and Reyes LF
- Subjects
- Humans, Colombia epidemiology, Retrospective Studies, Male, Female, Middle Aged, Adult, Klebsiella pneumoniae genetics, Klebsiella pneumoniae enzymology, Klebsiella pneumoniae drug effects, Klebsiella pneumoniae isolation & purification, Microbial Sensitivity Tests, Aged, Cross Infection microbiology, Cross Infection epidemiology, Carbapenems pharmacology, Community-Acquired Infections microbiology, Community-Acquired Infections epidemiology, Whole Genome Sequencing, Adolescent, Young Adult, beta-Lactamases genetics, beta-Lactamases metabolism, Bacterial Proteins genetics, Bacterial Proteins metabolism, Gram-Negative Bacterial Infections microbiology, Gram-Negative Bacterial Infections epidemiology, Gram-Negative Bacteria genetics, Gram-Negative Bacteria enzymology, Gram-Negative Bacteria isolation & purification, Gram-Negative Bacteria drug effects, Gram-Negative Bacteria classification, Anti-Bacterial Agents pharmacology, Pseudomonas aeruginosa genetics, Pseudomonas aeruginosa drug effects, Pseudomonas aeruginosa enzymology
- Abstract
In this study, the genetic differences and clinical impact of the carbapenemase-encoding genes among the community and healthcare-acquired infections were assessed. This retrospective, multicenter cohort study was conducted in Colombia and included patients infected with carbapenem-resistant Gram-negative rods between 2017 and 2021. Carbapenem resistance was identified by Vitek, and carbapenemase-encoding genes were identified by whole-genome sequencing (WGS) to classify the alleles and sequence types (STs). Descriptive statistics were used to determine the association of any pathogen or gene with clinical outcomes. A total of 248 patients were included, of which only 0.8% (2/248) had community-acquired infections. Regarding the identified bacteria, the most prevalent pathogens were Pseudomonas aeruginosa and Klebsiella pneumoniae . In the WGS analysis, 228 isolates passed all the quality criteria and were analyzed. The principal carbapenemase-encoding gene was bla KPC, specifically bla KPC-2 [38.6% (88/228)] and bla KPC-3 [36.4% (83/228)]. These were frequently detected in co-concurrence with bla VIM-2 and bla NDM-1 in healthcare-acquired infections. Notably, the only identified allele among community-acquired infections was bla KPC-3 [50.0% (1/2)]. In reference to the STs, 78 were identified, of which Pseudomonas aeruginosa ST111 was mainly related to blaKPC-3. Klebsiella pneumoniae ST512, ST258, ST14, and ST1082 were exclusively associated with bla KPC-3. Finally, no particular carbapenemase-encoding gene was associated with worse clinical outcomes. The most identified genes in carbapenemase-producing Gram-negative rods were bla KPC-2 and bla KPC-3, both related to gene co-occurrence and diverse STs in the healthcare environment. Patients had several systemic complications and poor clinical outcomes that were not associated with a particular gene.IMPORTANCEAntimicrobial resistance is a pandemic and a worldwide public health problem, especially carbapenem resistance in low- and middle-income countries. Limited data regarding the molecular characteristics and clinical outcomes of patients infected with these bacteria are available. Thus, our study described the carbapenemase-encoding genes among community- and healthcare-acquired infections. Notably, the co-occurrence of carbapenemase-encoding genes was frequently identified. We also found 78 distinct sequence types, of which two were novel Pseudomonas aeruginosa , which could represent challenges in treating these infections. Our study shows that in low and middle-income countries, such as Colombia, the burden of carbapenem resistance in Gram-negative rods is a concern for public health, and regardless of the allele, these infections are associated with poor clinical outcomes. Thus, studies assessing local epidemiology, prevention strategies (including trials), and underpinning genetic mechanisms are urgently needed, especially in low and middle-income countries., Competing Interests: This work was supported by MSD-Colombia, subsidiary of Merck & Co., Inc., Rahway, NJ, USA. Juan Urrego-Reyes, Claudia C. Beltran, and Sebastian Medina are MSD employees. This did not interfere with the authors' ability to analyze, interpret the data, or prepare the manuscript.
- Published
- 2024
- Full Text
- View/download PDF
48. Therapy of parapneumonic empyema in children: a protocol for a scoping review of the literature.
- Author
-
Buonsenso D, Cusenza F, Passadore L, Bonanno F, Calanca C, Rasmi S, Mariani F, and Esposito SMR
- Subjects
- Humans, Child, Child, Preschool, Infant, Adolescent, Pneumonia microbiology, Anti-Bacterial Agents therapeutic use, Community-Acquired Infections drug therapy, Community-Acquired Infections microbiology, Empyema, Pleural therapy, Empyema, Pleural microbiology
- Abstract
Background: Empyema (the presence of pus in the pleural space) is a severe complication of community-acquired pneumonia and significant cause of morbidity, but, fortunately, not mortality in children. Between 0.6 and 2% of pneumonias are complicated by empyema and the three main pathogens involved are Streptococcus pneumoniae, Staphylococcus aureus and group A Streptococcus 1,2,3,4. Optimal management in children, especially the choice of antibiotics, method of administration and duration of therapy, pleural dranage or surgery, are still a matter of debate and currently, lack of strong specific recommendations. This paper displays the study protocol for a scoping review that aims to summarize the available literature on the microbiological epidemiology, the medical and surgical treatment options, and the outcomes of pleural empyema in pediatric population., Methods: Comprehensive research combining the terms pediatric (children aged 0 to 18 years) and pleural empyema will be performed on PubMed and SCOPUS to identify all eligible studies. At first, two reviewers will screen the abstract and then their full text to determine the articles that meet the inclusion criteria. This work will be carried out independently, everyone on a different Excel spreadsheet and each researcher will be blinded to the decision of the other researcher. When the process is completed, in case of discordance, any disagreement will be identified and resolved through discussion or with help of a third author., Dissemination: The findings of this review will be published in a peer-reviewed journal., Competing Interests: No competing interests were disclosed., (Copyright: © 2024 Buonsenso D et al.)
- Published
- 2024
- Full Text
- View/download PDF
49. Impact of the COVID-19 pandemic on Haemophilus influenzae infections in pediatric patients hospitalized with community acquired pneumonia.
- Author
-
Ai L, Fang L, Liu B, Zhou C, and Gong F
- Subjects
- Humans, Male, Female, Child, Child, Preschool, Retrospective Studies, Infant, China epidemiology, Hospitalization, Adolescent, Pandemics, Coinfection epidemiology, Coinfection drug therapy, Coinfection microbiology, SARS-CoV-2 isolation & purification, SARS-CoV-2 drug effects, Drug Resistance, Bacterial, COVID-19 epidemiology, COVID-19 complications, Haemophilus influenzae drug effects, Haemophilus influenzae isolation & purification, Haemophilus Infections epidemiology, Haemophilus Infections drug therapy, Haemophilus Infections microbiology, Community-Acquired Infections epidemiology, Community-Acquired Infections drug therapy, Community-Acquired Infections microbiology, Anti-Bacterial Agents therapeutic use
- Abstract
The COVID-19 pandemic has altered the infection landscape for many pathogens. This retrospective study aimed to compare Haemophilus influenzae (H. influenzae) infections in pediatric CAP patients hospitalized before (2018-2019) and during (2020-2022) the COVID-19 pandemic. We analyzed the clinical epidemiology and antimicrobial resistance (AMR) patterns of H. influenzae from a tertiary hospital in southwest China. A total of 986 pediatric CAP patients with H. influenzae-associated infections were included. Compared to 2018, the positivity rate increased in 2019 but dropped significantly in 2020. Although it rose in the following 2 years, the rate in 2022 remained significantly lower than in 2019. Patients' age during the pandemic was significantly higher than in 2018 and 2019, while gender composition remained similar across both periods. Notably, there were significant changes in co-infections with several respiratory pathogens during the pandemic. Resistance rates of H. influenzae isolates to antibiotics varied, with the highest resistance observed for ampicillin (85.9%) and the lowest for cefotaxime (0.0%). Resistance profiles to various antibiotics underwent dramatic changes during the COVID-19 pandemic. Resistance to amoxicillin-clavulanate, cefaclor, cefuroxime, trimethoprim-sulfamethoxazole, and the proportion of multi-drug resistant (MDR) isolates significantly decreased. Additionally, MDR isolates, alongside isolates resistant to specific drugs, were notably prevalent in ampicillin-resistant and β-lactamase-positive isolates. The number of pediatric CAP patients, H. influenzae infections, and isolates resistant to certain antibiotics exhibited seasonal patterns, peaking in the winter of 2018 and 2019. During the COVID-19 pandemic, sharp decreases were observed in February 2020, and there was no resurgence in December 2022. These findings indicate that the COVID-19 pandemic has significantly altered the infection spectrum of H. influenzae in pediatric CAP patients, as evidenced by shifts in positivity rate, demographic characteristics, respiratory co-infections, AMR patterns, and seasonal trends., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
50. Distribution of virulence genes in clinical isolates of hospital-associated and community-associated methicillin-susceptible Staphylococcus aureus from Terengganu, Malaysia.
- Author
-
Che Hamzah AM, Yeo CC, Puah SM, Chua KH, A Rahman A, Ismail S, Abdullah FH, Othman N, and Chew CH
- Subjects
- Malaysia, Humans, Middle Aged, Female, Male, Adult, Aged, Virulence genetics, Young Adult, Child, Adolescent, Anti-Bacterial Agents pharmacology, Child, Preschool, Staphylococcal Infections microbiology, Staphylococcal Infections epidemiology, Virulence Factors genetics, Community-Acquired Infections microbiology, Community-Acquired Infections epidemiology, Staphylococcus aureus genetics, Staphylococcus aureus pathogenicity, Staphylococcus aureus isolation & purification, Staphylococcus aureus drug effects, Cross Infection microbiology, Cross Infection epidemiology
- Abstract
Staphylococcus aureus is a common bacterial pathogen known to cause various kinds of infections due to its repertoire of virulence factors. This study aimed to investigate the distribution of 19 types of virulence genes among clinical isolates of methicillin-susceptible S. aureus (MSSA) using the polymerase chain reaction. A total of 109 MSSA isolates, i.e., 63 hospital-associated (HA) and 46 community-associated (CA) were collected from Hospital Sultanah Nur Zahirah, the main tertiary hospital in Terengganu, Malaysia, from July 2016 to June 2017. The most frequent virulence genes detected were hla (78.9%, n=86) and hld (78.0%, n=85) encoding hemolysins, lukED (56.9%, n=62) encoding leukotoxin ED, followed by seb (26.6%, n=29) and sea (24.8%, n=27) encoding enterotoxins. Among 34 (31.2%) isolates carrying six or more virulence genes, only five were multidrug resistant (MDR) while the remaining isolates were susceptible. Significant associations were discovered between the hld gene with CA-MSSA (p=0.016) and the seo gene with HA-MSSA (p=0.023). However, there is no significant association between virulence genes among the different types of infection. The clinical MSSA isolates in Terengganu showed high prevalence and high diversity of virulence gene carriage.
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.